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ABBREVIATIONS 
2D Two-dimensional 
3D Three-dimensional 
A-mode Display presentation of echo amplitude versus depth 
ASD Atrial septal defect 
AVSD Atrioventricular septal defect 
BPD Biparietal diameter 
B-mode Brightness mode (gray scale mode), display presentation of a spot 
brightening for each echo voltage delivered from the receiver 
CHD Congenital heart defect 
CNS Central nervous system 
CRL Crown-rump length 
CW Continuous wave 
DIRV Double inlet right ventricle 
DORV Double outlet right ventricle 
HLHS Hypoplastic left heart syndrome 
IUFD Intrauterine fetal death 
IQ data Complex demodulated radio frequency data 
MHz Megahertz 
MRI Magnetic resonance imaging 
STIC Spatio-temporal image correlation 
TDOG Tissue Doppler gated 
TGA Transposition of the great arteries 
TOF Tetralogy of Fallot 
TOP Termination of pregnancy 
VSD Ventricular septal defect 
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INTRODUCTION 
Background 
The aim of prenatal care has always been to prevent and alleviate maternal and 
fetal/newborn complications affecting the pregnancy, birth and the neonatal period. 
Traditionally, midwives and general practitioners have provided the basic prenatal care 
in Norway. Selection of high-risk pregnancies for referral to obstetric specialists has 
been an important part of the pregnancy care. 
 
In 1982, a study analyzing stillbirths and neonatal deaths from five counties in Norway 
found that 30% of the deaths might have been avoided with provision of optimal care 
(Larssen et al. 1982). As a consequence, the Directorate of Health in Norway ordered 
guidelines to be developed in 1984 to ensure equal and complete prenatal care for all 
pregnant women in Norway (Norges offentlige utredninger, NOU 1984:17). The 
document outlined the organization of the pregnancy care in the future, but gave little 
attention to the potential of diagnostic ultrasound for future prenatal diagnosis and 
treatment. This laid the ground for an intense debate among obstetricians concerning the 
use of ultrasound in pregnancy in Norway in the following years. In 1986, a consensus 
conference concerning the use of ultrasound in pregnancy was organized. An 
implementation of one ultrasound examination at 17–18 weeks of gestation for all 
pregnant women in Norway was recommended (Backe and Buhaug 1986). Since then, 
the use of obstetric ultrasound has continuously expanded in Norway. It now represents 
the method of choice for diagnosis and treatment in pregnancy, and addresses the 
problems concerning the 30% deaths that might have been avoided with improved 
prenatal care (Larssen et al. 1982, Holt et al. 2000). 
 
History of ultrasound 
The Italian biologist Lazzaro Spallanzani demonstrated already in 1794 the ability of 
bats to navigate with the aid of echo reflections from high frequency inaudible sound. 
The scientific work towards defining the fundamental physics of sound vibrations, 
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transmission, propagation and refraction then followed in the centuries thereafter. This 
included the thesis by Lord Rayleigh from England in 1877, “The Theory of Sound”; 
this was the first description of a sound wave as a mathematical equation, and the 
foundation for future theoretical work in acoustics. For his work, Lord 
Rayleigh received the Nobel Prize in 
physics in 1904 (Woo 2005). Sir 
Francis Galton was able to generate 
high frequency sound waves in 1876 
using the so-called “Galton Whistle” 
which he developed (Figure 1). 
 
 
Figure 1  A Galton Whistle from 1915. 
(http://www.entlink.net/museum/gems2.cfm 
[Accessed 18 February 2006]).
The real breakthrough for high 
frequency echo-sounding techniques 
came in 1880 when Pierre Curie and his 
brother Jacques Curie discovered the 
piezo-electric effect in certain crystals 
(Curie and Curie 1880) (Figure 2). 
 
 
Figure 2  The piezo-electric effect. An applied 
pressure converts electric voltage into 
ultrasound pulses and convert returning echoes 
back into voltages. 
 
The Titanic tragedy in 1912 prompted research to detect underwater objects such as 
icebergs. The first working sonar system was designed in 1914, but was not particularly 
successful. World War I gave rise to new studies, as it became important to detect other 
underwater objects such as submarines. Among others, the French physicist Paul 
Langévin and the Russian scientist Constantin Chilowsky developed the hydrophone, a 
powerful high frequency ultrasonic echo sounding device involved in the sinking of a 
German submarine in the Atlantic in 1916 during World War I. Langévin’s 
hydrophones formed the basis of the future development of naval pulse-echo SONAR 
(Sound Navigation and Ranging) in the following years. Later the RADAR (Radio 
Detection and Ranging) system was developed, using electromagnetic waves rather than 
ultrasonic waves (Woo 2005). 
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The next important step was the development of pulse-echo ultrasonic metal flaw 
detectors in the 1930s (Figure 3). They were primarily constructed to check on the 
integrity of metal hulls of large ships and the armour plates of battle tanks (Figure 4). 
Together with the sonar and radar systems, the metal flaw detectors were precursors for 
the establishment of medical ultrasonic equipment (Woo 2005). 
 
  
Figure 3  Metal flaw detector. Note, Figure 4  Interruptions in the passage of sound waves 
camera supported by a wooden log! are used to locate and measure flaws and cracks in solid 
(Edler 1961). metal (Woo 2005). 
 
Early medical use of ultrasound 
Ultrasound is a relatively new modality within medicine and was initially used for 
therapy rather than diagnosis. In 1938, Raimar Pohlman, in Erlangen, Germany, 
demonstrated the therapeutic effects of ultrasonic waves in human tissue and introduced 
ultrasonic physiotherapy as a medical practice (Figures 5-7). 
 
  
Figure 5  Ultrasonic physiotherapy Figure 6  Ultrasonic therapy generator, the  
(Woo 2005). “Medi-Sonar” in the 1950s. 
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William Fry, University of Illinois, and Russell Meyers, University of Iowa, used 
ultrasound to destroy parts of the basal ganglia during craniotomies in patients with 
Parkinsonism. During the 1940s, 
ultrasound was regarded as a “cure-all” 
remedy, despite the lack of scientific 
evidence. The question of possible 
harmful tissue damaging started to be 
raised, and consequently curtailed the 
development of diagnostic ultrasound 
for a time (Woo 2005). 
 
 
Figure 7  Treatment of ulcer (Woo 2005). 
 
Early pioneers within diagnostic ultrasound were the Austrian neurologist Karl 
Theodore Dussik and his brother Friederich who were the first to use ultrasound for 
diagnostic purposes. They studied sound attenuation in brain tissue in the early 1940s, 
but their method was later described as worthless. George Ludwig, a physician from 
USA, investigated the use of ultrasound for the detection of gallstones (outside the 
human body) in the late 1940s (Ludwig and Struthers 1950). John Wild and John M. 
Reid built the first handheld B-mode scanner for clinical use in 1951 (Baker 2005, Woo 
2005). 
 
Ultrasound in cardiology 
The development of ultrasound technology to be used in the field of cardiology started 
as a cooperation between cardiologist Inge Edler and physicist Carl Hellmuth Hertz in 
Lund, Sweden, in 1954 (Figure 8). In 2004 the 50th anniversary of this important 
scientific work in cardiology was celebrated (Olsson et al. 2004). This work has 
developed extensively and completely changed the diagnostic tools for adult cardiology. 
It is also the foundation for today’s fetal cardiology. Edler and Hertz utilized the metal 
flaw detectors as a basis for their research (Edler 1961). The need for improved 
diagnosis before heart surgery led Edler to look for non-invasive alternatives rather than 
cardiac catheterization and contrast x-rays of the heart that failed to give enough 
preoperative information, for example, about the mitral valve (Nilsson and Westling 
  
 15 
2004). For the first time in October 29, 1953, Inge Edler and Carl Hellmuth Hertz 
managed to record pictures from the heart (Edler and Hertz 1954). With a single sound 
beam aimed in a fixed direction through the heart, the various echoes in this sound 
beam could be recorded as a function of time, the so-called M-mode (motion) 
registration. Later on, Edler and his colleagues realized that some of the echoes came 
from the anterior leaflet of the mitral valve and the characteristic motion pattern for this 
valve was soon established (Figure 9). Edler and Hertz’s work made a decisive 
contribution to diagnostics in cardiology, neurosurgery and obstetrics and gynecology 
(Nilsson and Westling 2004). 
 
  
Figure 8  Inge Edler and Carl Hellmuth Hertz Figure 9  Echo pattern records of the motion of the 
(Nilsson and Westling 2004).  anterior leaflet of the mitral valve. Left: normal 
pattern, right: schematic representation in a normal 
case (Edler 1961). 
Ultrasound in obstetrics 
Ian Donald from Scotland was the first to introduce diagnostic ultrasound to obstetrics 
and gynecology. His 1958 publication in the Lancet, “Investigation of abdominal 
masses by pulsed ultrasound”, was the most important paper published on medical 
diagnostic ultrasound at that time and boosted the later clinical development (Donald et 
al. 1958). Ian Donald and his engineering group developed the Diasonograph produced 
by Nuclear Enterprise (Figure 10). He was the first to perform fetal head measurements 
and related them to age and weight (Willocks et al. 1964, Willocks et al. 1967), and the 
first to report sonographic evidence of a gestational sac (MacVicar and Donald 1963). 
Ian Donald also utilized ultrasound to study ovarian cysts, polyhydramnios and molar 
pregnancy (Donald et al. 1958, Donald 1962). 
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Inspired by Ian Donald, Bertil Sundén, at the University of Lund, took an early interest 
in obstetric and gynecological ultrasound and safety. Upon the publication of Ian 
Donald’s work on the echoscope generating a two-dimensional display, Sundén was 
sent to visit and work in Donald’s department in Glasgow for three weeks. As a 
consequence, Nuclear Enterprise sold 
their very first Diasonograph to the 
department of Obstetrics and 
Gynecology in Lund. Bertil Sundéns 
book titled “On the diagnostic value of 
ultrasound in obstetrics and 
gynæcology” from 1964 was the first 
thesis addressing the use of 
ultrasonography in obstetrics and 
gynecology (Sundén 1964). His thesis 
represented pioneer work with  
 
Figure 10  Diasonograph – Nuclear Enterprise 
(Sundén 1964).
numerous first-time observations including an anencephalic fetus diagnosed at 31 weeks 
of gestation. 
 
The pioneers in the development of transvaginal transducers were Hisaya Takeuchi 
from Japan and Alfred Kratochwil from Austria. Already in the late 1960s they reported 
on fetal heart pulsation in the early first trimester (Kratochwil and Eisenhut 1967, 
Takeuchi et al. 1968). Working with KretzTehnik AG in Austria, Kratochwil soon 
became an active user of the technique and from 1968 developed training courses in 
ultrasound (Woo 2005). 
 
Until the mid-1970s, A- and B-mode scanners were used. In 1968, Stuart Campbell, in 
London, published his now classical paper “An improved method of fetal cephalometry 
by ultrasound” which immediately became a highly recognized work in which both A- 
and B-mode scans were used to measure the fetal biparietal diameter, today a standard 
measurement in fetal biometry (Campbell 1968). Utilizing a static B-scan, Campbell 
was the first to report on prenatal detection of an anencephalic fetus (Campbell et al. 
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1972) and a fetus with spina bifida (Campbell 1977), resulting in a termination of 
pregnancy. In 1975, Hugh Robinson, in Glasgow, reported on the measurement of the 
fetal crown-rump length; his measurement curves are still in use today (Robinson 1973). 
By combining A- and B-mode ultrasound, Robinson successfully demonstrated fetal 
cardiac action from 7 weeks onwards (Robinson and Shaw-Dunn 1973). The advent of 
the analog scan converter in the early 1970s and the digital scan converter in the later 
1970s were among the most important innovations in ultrasound imaging (Woo 2005). 
 
The first mechanical real-time scanner was developed in Germany by Walter Krause 
and Richard Soldner in the 1960s. They used a rotating transducer and a parabolic 
mirror, sending the sound waves parallel into the tissue (Figure 11). A wide picture in 
real-time sequences of more than 10 frames per second could be obtained. This 
technique completely changed the practice of ultrasound scanning. 
 
  
Figure 11  Videoson Siemens Medical Systems 1965, and its working mechanism. 
 
Years of further development ensued. In 1973, one of the earliest commercial models of 
a linear-array real-time scanner was designed and produced by Martin H. Wilcox, the 
founder and engineer at the Advanced 
Diagnostic Research Corporation 
(Figure 12). In 1986, these electronic 
real-time scanners started to replace the 
static scanners. 
  Figure 12  The ADR real-time scanner.
Mirror 
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Doppler ultrasound 
The Doppler effect was first described by the Austrian physicist Christian Johann 
Doppler (1803–1853) in 1842. Echoes returned from moving objects have frequencies 
different from the frequencies sent into the body. This is called the Doppler effect. The 
change in frequency is called the Doppler shift, which might be used to detect and 
measure tissue motion, the presence or absence of blood flow and its direction, speed 
and character. 
 
Figure 13  Satomura 1959. 
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Of importance for the use of ultrasound technology in the diagnosis of heart defects was 
the development of Doppler ultrasound technology (Satomura 1957, Satomura 1959 
(Figure 13), Baker et al. 1964, Peronneau et al. 1969). 
 
In Trondheim, research on the Doppler 
technique started in 1973. One 
instrument, PEDOF, Vingmed, 
(Figure 14) combined the use of 
continuous wave ultrasound for the 
measurement of high velocities, such as 
in a stenosis, with the pulsed wave 
ultrasound for blood flow measurements 
at a pre-selected depth. This laid the 
foundation for the future development 
 
Figure 14  Daisy and Pedof, Doppler  
unit and spectrum analyzer, Vingmed 
(Hatle and Angelsen 1982)
of ultrasound in cardiology (Brubakk et al. 1977, Hatle et al. 1978). Later, the imaging 
ultrasound technique and Doppler ultrasound technique were combined in the same 
instrument, thereby making color-flow mapping and detailed registration of velocities in 
selected vessels possible (Hatle et al. 1980, Hatle et al. 1981). 
 
In 1977, FitzGerald and Drumm managed to register crude Doppler ultrasound signals 
from the human fetus in utero (Fitzgerald and Drumm 1977). A year later McCallum et 
al. (1978) presented various types of waveforms from the umbilical cord in utero. In 
1979, Gill and Kossoff managed to quantify the blood flow in the umbilical vein (Gill 
and Kossoff 1979). Their system, however, did not allow measurements of the high 
velocities present in fetal arteries. In 1978, Eik-Nes et al. started the work that 
culminated in the first prototype of a Duplex transducer combining a linear array 
transducer and a pulsed Doppler transducer for the qualitative and quantitative 
measurement blood flow in fetal arteries as well as veins (Eik-Nes et al. 1980, Eik-Nes 
et al. 1982, Kirkinen et al. 1983, Eik-Nes et al. 1984b, Maršál et al. 1984). 
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The use of Doppler ultrasound in obstetrics emerged late in the 1970s. Further 
development led to 2D color flow imaging (Angelsen et al. 1989). With rapid 
interfacing of 2D and Doppler ultrasound, color-coded presentations of Doppler 
information superimposed on gray-scale anatomic images were possible. Appropriate 
colors were assigned to the display pixels depending on whether the motion was toward 
or away from the transducer. 
 
Color Doppler ultrasound is considered to be a second-line investigation for cardiac 
evaluation and completes the evaluation of the gray-scale information (Chaoui 2001). It 
allows for ascertainment of homogenous flow within the heart in the great vessels to 
rule out heart defects and a more detailed diagnosis once heart disease is suspected. 
Color Doppler may also highlight areas of turbulence or of important atrioventricular 
valve regurgitation and for assessment of valve opening and of symmetry in ventricular 
filling in cases where visualization using the gray scale alone is difficult (Chaoui 2001, 
Gardiner 2001). 
 
Power Doppler ultrasound 
Power Doppler displays present two-dimensional Doppler information by color-
encoding the strength of the Doppler shift. This method is free of aliasing, is not angle 
dependent, and is more sensitive than pulsed Doppler ultrasound to slow flow and flow 
in small or deep vessels (Kremkau 2006). On the other hand, power Doppler does not 
give information about direction, speed and flow character such as turbulence. 
 
Power Doppler ultrasound was introduced in the early 1990s and has opened up the 
possibility of displaying flow independently of its velocity or direction. The technique is 
useful when applied to fetal cardiology; it facilitates the detection of small VSDs and 
enables spatial orientation of the great arteries (Chaoui 2001). 
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Three- and four-dimensional ultrasound 
Three-dimensional ultrasound is a logical development of 2D imaging because the 
anatomy in reality is three-dimensional. Already in 1977, Brinkley et al. described a 
technique to generate a three-dimensional reconstruction of an organ, later applied to 
fetuses for weight estimation (Brinkley et al. 1982, Eik-Nes and Brinkley 1983). The 
technique described by Brinkley made possible crude 3D still-images of the fetal heart. 
 
The heart is a moving object. In adult cardiology it is possible to synchronize (gate) the 
imaging of the heart movements in relation to the echocardiogram. Since this is not 
possible, or very difficult, in the fetus, other methods to cope with the temporal 
information had to be found. These methods are called “gating”. In 1996, Nelson et al. 
reported on possibilities examining the fetal heart by 3D and 4D ultrasound using a fast 
Fourier transform method, similar to what we today know as STIC. The same year, 
Deng et al. (1996) used real-time directed M-mode to gate the fetal heart rate and 
acquire and display 4D volume data sets of the fetal heart. The fetal heart rate acquired 
by Doppler ultrasonography (Deng et al. 2000, Meyer-Wittkopf et al. 2001, Herberg et 
al. 2005) or by cardiotocography (Herberg et al. 2003) has also been used to gate the 
spatial and temporal information. These described methods use a post processing 
technique. It would be of interest to find a technique that makes it possible to gate the 
images during the acquisition of data. In the future, it will be possible to obtain this by 
tissue Doppler gated technique and a 2D-array system. 
 
The reported advantages of 3D over conventional 2D imaging are reduced scanning 
time, and reduced operator dependency and window dependency since the volumetric 
data are acquired within a few seconds from a single window. Another advantage is that 
access to volume data may provide information not obtainable with 2D ultrasound. In 
3D ultrasound a volume of ultrasonographic data is acquired and stored, allowing the 
subsequent extraction of an infinite number of scan planes (Budorick and Millman 
2000, Downey et al. 2000).  
 
  
 22 
4D visualization of the fetal heart became a reality with the incorporation of STIC 
(spatio-temporal imaging correlation) algorithms into commercially available 
equipment (Gonçalves et al. 2005). The processing using STIC is done retrospectively. 
 
Magnetic Resonance Imaging (MRI) 
MRI has developed to become a powerful approach to imaging CHD in infants and 
children (Chung 2000). The potential of MR for imaging the fetus was described in 
1983 by Smith et al. (1983). MRI has proven to be a valuable complement to 
ultrasonography when additional information is needed about fetal anatomy (Levine et 
al. 1999a). Traditionally, MRI has been used to evaluate the maternal pelvic anatomy, 
but the fetal anatomy has been difficult to image because of fetal motion during the 
relatively long acquisition times (Weinreb et al. 1985, Powell et al. 1988). The 
development of fast MRI techniques has revolutionized the ability to image both the 
pregnant woman and the fetus (Levine et al. 1996). 
 
Ultrasound evaluation of fetal anatomy may be limited by the nonspecific appearance of 
some anomalies, by artifacts that reduce the image resolution and by advanced 
gestational age. MRI uses no ionizing radiation, provides excellent soft tissue contrast 
and has multiple planes for reconstruction and a large field of view. Thus, it is the 
method of choice when additional information is needed following ultrasound diagnosis 
(Levine 2001). In such cases MRI may give valuable information to add for the 
counseling process (Levine et al. 1999a, Knox et al. 2005). MRI has proven to be 
particularly beneficial in the evaluation of the fetal CNS system (Blaicher et al. 2005), 
especially in ventriculomegaly and imaging of the corpus callosum (Levine et al. 
1999b) and when therapeutic consequences might be expected, such as diaphragmatic 
hernia, tumors (Knox et al. 2005) and fetal abdominal masses (Angtuaco et al. 1992). 
Because of signal-to-noise limitations, small fetal structures may be difficult to image 
by MRI (Blaicher et al. 2005), thus the fetal heart may be difficult to visualize and the 
interventricular septum and the atrioventricular valves may only occasionally be seen 
(Trop and Levine 2001). The claustrophobic factor for those inside the magnet and the 
vena cava syndrome often occurring in the third trimester of the pregnancy may be 
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factors that need to be addressed when imaging the fetus (Levine et al. 1999a). 
Increased experience with fast MRI techniques and ’real-time’ cardiac MRI will most 
likely identify more conditions where this technique may add to the prenatal diagnosis 
(Fogel et al. 2005).  
 
The fetal examination 
Ultrasound technique made it possible to get information directly from the fetus in a 
non-invasive manner. As the development of this technique and equipment continued, 
the use of ultrasound in pregnancy rapidly expanded. It became obvious that ultrasound 
technology could reveal conditions not detectable by traditional ways of collecting 
information from the pregnant woman and the fetus. 
 
The first screening program for systematic use of ultrasound in pregnancy was initiated 
in Malmö, Sweden, in 1974, starting with one ultrasound examination at 28 weeks of 
gestation. The primary intention was to detect twins. In the following years, the 
examination was successively moved to 17 weeks. From 1976 a second routine 
examination was included at 32 gestational weeks (Grennert et al. 1978). In 1980, 
Germany was the first country to officially introduce the two-stage screening program, 
adopted from Malmö, to their total pregnant population (Mutterschafts-Richtlinien 
1980). In Norway, a consensus conference concerning the use of ultrasound in 
pregnancy was held in Oslo in 1986. The consensus panel recommended the offer of 
one ultrasound examination at approximately 18 weeks to all pregnant women (Backe 
and Buhaug 1986). The recommendation was based on the reported decrease in post-
term pregnancies following introduction of routine ultrasound (Eik-Nes et al. 1984a) 
and the need to organize the already extensive use of ultrasound in pregnancy (Eik-Nes 
1986), later confirmed by Backe (1994). In the years that followed, routine ultrasound 
scanning was officially introduced by the health authorities in a number of European 
countries. Iceland followed the Norwegian one-stage model in 1987 (Geirsson 1987), 
and Austria followed the German two-stage model in 1988. In 1995, Germany 
expanded their official offer with an early scan at 10 weeks (Änderung der 
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Mutterschafts-Richtlinien 1995), and in 1996, Switzerland introduced an early scan at 
10 weeks followed by an 18 week scan. Although not all countries have introduced the 
practice officially, most countries offer ultrasound examinations to their pregnant 
population today (SBU-rapport nr. 139, 1998). 
 
Randomized controlled trials were carried out during the 1980s with the purpose of 
showing any benefit of using ultrasound in every pregnancy (Bennet et al. 1982, Eik-
Nes et al. 1984a, Bakketeig et al. 1984, Neilson et al. 1984, Waldenström et al. 1988, 
Saari-Kemppainen et al. 1990, Eik-Nes et al. 2000). One problem with such studies is 
that the window for carrying them out is narrow. A study evaluating a new technique 
too early, before it is fully developed, may not show the full benefit of the technique 
studied. If it is done too late, the technique may already be in use and the information 
needed for comparison is no longer available (Eik-Nes 1993a, Salvesen and Eik-Nes 
1994). The early findings in the controlled trials included a more precise estimate of the 
gestational age, resulting in a 70% reduced frequency of induction for overdue 
pregnancies (Eik-Nes et al. 1984a, Waldenström et al. 1988, Neilson 2004) and a 
reduction in perinatal mortality mainly due to improved early detection of major 
anomalies (Saari-Kemppainen et al. 1990). 
 
Other studies evaluated the effectiveness of the routine examination to detect fetal 
developmental disorders (Chitty et al. 1991, Crane et al. 1994, Papp et al. 1995, 
Grandjean et al. 1999, Vial et al. 2001, Garne et al. 2005, Dolk 2005). Due to 
differences in use of ultrasound in pregnancy and in experience of the operators, the 
results varied between 35–74%. Once detected, various conditions could be followed 
and information derived from prenatal observations and follow-up through delivery and 
into the neonatal period. With such information, follow-up of the fetus and child has 
been optimized to improve perinatal mortality and morbidity (Bonnet et al. 1999, 
Brantberg et al. 2004). 
 
Traditionally, pregnant women at increased risk of having a fetus with congenital heart 
defect have been referred to specialist for an additional ultrasound examination (Allan 
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et al. 1986a). In the 1980s, pediatric cardiologists clearly saw the potential of ultrasound 
techniques such as M-mode, two-dimensional and Doppler echocardiography, 
techniques utilized for the fetal heart examination in high-risk pregnancies (Kleinman et 
al. 1980, Huhta 1986). In 1985, a French study first initiated the idea of prenatal cardiac 
screening (Fermont et al. abstract 1985), closely followed by Allan et al. (1986b). They 
suggested that 2/1000 major CHDs could be detected by including the four-chamber 
view into the second trimester fetal examination. It was soon realized that fetal heart 
defects were more difficult to detect than major defects in other fetal organs, 
particularly in non-selected populations (Brocks and Bang 1991, Crane et al. 1994, 
Rustico et al. 1995, Tegnander et al. 1995, Buskens et al. 1996, Bull 1999, Wong et al. 
2003). 
 
With the improvement in ultrasound technology, more and more details of the fetal 
heart could be imaged at an earlier gestation (Achiron et al. 1994, Allan et al. 1997). 
Data also showed that in the group of fetuses at increased risk for CHD, only a small 
percentage of the total CHD-population was found (Allan et al. 1994, Maher et al. 
1994, Carvalho et al. 2002, Åmark et al. 2004). Most fetuses with CHD were born from 
mothers at no increased risk at all, thus the second trimester fetal examination became 
important for the prenatal detection of CHDs. 
 
The poor detection rates of major CHDs from non-selected populations needed to be 
addressed. The equipment used, the gestational age at the time of the fetal examination 
and details obtained from the fetal heart were factors that had to be evaluated. The 
ultrasound machines used for second trimester screening purposes were often of poorer 
quality than the equipment used at referral centers. This was a paradox, since in order to 
make a referral for second opinion, the CHD had to be suspected when the routine scan 
was made; thus, good quality machines should be available in routine ultrasound 
settings. But, even with an ultrasound with poor quality, it is necessary to be able to use 
the potential of the machine to create optimized ultrasound images in order to detect 
developmental disorders in general. In addition, the gestational age seems important in 
imaging anatomical structures. Several studies have shown that examination of the fetal 
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heart prior to 18 gestational weeks is too early to obtain details from the heart; thus, the 
fetal heart examination should be done after 18 weeks, preferably after 20 weeks 
(Schwärzler et al. 1999b, Allan 2003). The various ways of organizing the use of 
ultrasound in pregnancy and the upper limit for termination of the pregnancy are 
decisive factors for setting the optimal time for the second trimester fetal examination. 
During the last years, the 11–13+6 week ultrasound examination has been introduced 
(Nicolaides et al. 1992). Increased nuchal translucency has proven to be a marker for 
chromosome aberrations, congenital heart defects and other defects such as 
diaphragmatic hernia and genetic syndromes (Nicolaides et al. 1992, Hyett et al. 1997, 
Hafner et al. 1998a, Schwärzler et al. 1999a, Souka et al. 2001, Haak et al. 2002, Hyett 
2002). Due to the fact that the fetal heart is tiny at that time of gestation, that an 
increased nuchal translucency may not be present in all CHDs, and because of the 
progression of CHDs during the time of the pregnancy, some heart defects may not be 
detected at such an early gestation (Maeno et al. 1999, Gardiner 2001, Mavrides et al. 
2001, Trines and Hornberger 2004).  
 
Epidemiology of congenital heart defects 
Congenital heart defect is one of the most common serious congenital anomalies found 
in live births with a reported incidence of 8/1000 live births (Mitchell et al. 1971). The 
use of ultrasound in non-selected populations has resulted in new information about the 
incidence, range and natural history of congenital heart defects seen prenatally (Allan 
1989). 
 
Incidence of CHDs 
Traditionally, the incidence of CHDs in large non-selected populations has been 
reported to be 8/1000 live births, of these, 4/1000 as major CHDs and 4/1000 as minor 
CHDs. A large variety of incidences are found from published data, between 3–12/1000 
live births (Carlgren 1969, Mitchell et al. 1971, Hoffman and Christianson 1978, 
Dickinson et al. 1981, Ferencz et al. 1985, Meberg et al. 1990). The lower incidences 
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were reported before there were well-trained pediatric cardiologists and before cardiac 
surgery required a detailed preoperative diagnosis (Hoffman 1995a). The introduction 
of the ultrasound technique, including Doppler ultrasound and Color Flow Mapping, has 
made it possible to diagnose minor CHDs and even asymptomatic CHDs postnatally 
(Martin et al. 1989, Meberg et al. 1994), and has thus resulted in an increase in the 
reported incidence of CHDs. 
 
Fetal population versus postnatal population 
Most studies from large populations evaluating the incidence of CHD have been based 
on postnatal populations (Mitchell et al. 1971, Dickinson et al. 1981, Ferencz et al. 
1985, Samánek et al. 1989). In postnatal populations, the ascertainment of cases might 
be biased due to asymptomatic CHDs that are missed at the ordinary clinical exam 
(mild pulmonary stenosis, small ASDs or VSDs), incorrectly diagnosed cause of death, 
deaths prior to recognized CHD and intrauterine deaths and postnatal deaths without 
autopsy (Abu-Harb et al. 1994, Hoffman 1995a). 
 
With the introduction of prenatal ultrasound, the natural history of CHDs could be 
studied. Some forms of CHD were seen more frequently prenatally than postnatally; 
some conditions, like HLHS, AVSD and critical aortic stenosis, were often presented 
with intrauterine heart failure, and a particularly high rate of chromosome aberrations 
was found among fetuses with CHD resulting in a high rate of intrauterine fetal deaths 
(Allan 1989). A high incidence of CHD and chromosome aberrations among 
spontaneously aborted fetuses has also been found (Gerlis 1985, Chinn et al. 1989). 
This suggests that the true incidence of CHD in early fetal life may be higher than what 
our knowledge from born populations would lead us to believe. 
 
Selected versus non-selected populations 
It has been a well-established routine to offer one extra ultrasound examination at 20–24 
weeks of gestation when there is an increased risk for CHD (Callan et al. 1991, Allan et 
al. 1994, Oberhänsli et al. 2000). Maternal factors that might increase the risk are 
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family history of CHD; previous child affected; parental CHD; maternal diabetes; 
exposure to known cardiac teratogens (such as alcohol, amphetamine, anticonvulsants), 
intrauterine infections (rubella, parvovirus, coxackievirus, cytomegalovirus) or high 
doses of ionizing radiation. Fetal factors are findings of nonimmune fetal hydrops, extra 
cardiac anomalies or arrhythmia (Allan 1989, Allan et al. 1994, Gembruch and Geipel 
2003). Because of the increased risk of CHD among these fetuses, the ultrasound 
examinations have been done by obstetric ultrasound specialists or pediatric 
cardiologists utilizing advanced ultrasound equipment. The detection rates of CHDs 
from selected populations have thus been reported as high as 92% (Copel et al. 1987, 
Stewart et al. 1987). Despite the high detection rates, the CHDs detected constituted 
only a small percentage of the total CHD population, as most fetuses with CHD are 
found in non-selected populations (Allan et al. 1994, Maher et al. 1994, Carvalho et al. 
2002, Åmark et al. 2004). 
 
As routine ultrasound became an integrated part of prenatal care, an increasing number 
of women at no risk for disease were being referred to tertiary centers because of 
abnormal fetal hearts seen at ultrasound examinations (Allan et al. 1994, Sharland 
2004). With new knowledge about where to find the CHDs, the focus changed towards 
fetal routine ultrasound in non-selected populations. The ultrasound operators were not 
as skilled, and the ultrasound machines not as advanced among those working with non-
selected populations as among to those working with selected populations at tertiary 
centers. In addition, the low incidence of malformations in non-selected populations 
made defects harder to find. CHDs seemed particularly difficult to detect, as the 
reported detection rates were lower than expected, and lower than the results from 
selected populations (Crane et al. 1994, Buskens et al. 1996, Bull 1999). Thus, 
investigating ways to increase the detection rate of CHDs in non-selected populations 
became important.  
 
Major and minor CHDs 
There does not seem to be a universally accepted definition of major CHD (Allan et al. 
2001). As a result, studies define major CHDs in various ways depending on the study 
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design, the population defined and the experience of the authors (Ferencz et al. 1990, 
Wren et al. 2000, Allan et al. 2001). These differences are reflected in the reported 
incidences of CHDs. Most investigators define major CHDs as defined by Mitchell et 
al. (1971) as a gross structural abnormality of the heart that is actually or potentially of 
functional significance (Hoffman 1995b, Allan et al. 2001). 
 
For many years, an incidence of CHD of 8/1000 live births has been accepted in non-
selected populations (Achiron et al. 1992, Boldt et al. 2002, Wong et al. 2003), whereas 
4/1000 as major CHDs. New data show that the incidence of major CHDs has remained 
unchanged (Carvalho et al. 2002). One may conclude that the majority of the major 
CHDs have always been recognized, thus an incidence of approximately 4/1000 reflects 
proper ascertainment of the major CHD cases.  
 
The incidence of minor CHDs, on the other hand, has steadily increased during the last 
years (Martin et al. 1989, Meberg et al. 1994, Roguin et al. 1995). Better postnatal 
clinical diagnosis and technique utilizing diagnostic ultrasound have resulted in an 
increased detection of minor CHDs previously not diagnosed. These are defects with 
little long-term consequences for the child and a vast majority close spontaneously 
within the first year after birth (Evans et al. 1960, Du et al. 1998, Helgason 1999, 
Meberg et al. 2000). There is reason to believe that the closure of these small defects 
towards the end of the pregnancy and during the first months of life may be a delay of a 
normal process, thus it might be questioned whether these defects are true congenital 
heart defects (Ben-Shachar et al. 1985, Hiraishi et al. 1992). As long as they are defined 
as CHDs, however, they will affect the incidence of CHDs in the population. 
 
Obviously we have to reconsider the incidence of CHDs and the spectrum of CHDs as 
new data emerge. 
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The fetal heart examination 
Real-time 2D ultrasound still is the best ultrasound technique for structural evaluation 
of the fetal heart. The technical development has resulted in ultrasound machines with 
advanced features such as high image resolution and high frame rate, making it possible 
to obtain a detailed image of the tiny structures in the moving fetal heart (Chaoui 2001). 
For routine use in the second trimester, the ultrasound examinations are most often 
performed transabdominally. As the attenuation factor some times limits imaging depth 
(Kremkau 2006), especially in obese women, alternative routes for examination may be 
preferred. Kratochwil and Eisenhut (1967), Takeuchi et al. (1968) and Jouppila (1971) 
were the first to propose the transvaginal route to identify fetal heart pulsations. With 
real-time transvaginal transducers, the fetal heart could be imaged in detail, resulting in 
the first publication, in 1990, of a CHD detected at 11 weeks of gestation (Gembruch et 
al. 1990). 
 
The first studies based on real-time images of the fetal heart were published in 1980 by 
Lindsey Allan et al. (1980), Kleinman et al. (1980) and Lange et al. (1980). Lindsey 
Allan’s work from the early 1980s laid the basis for subsequent studies showing that 
fetal cardiac anomalies could be detected by real-time ultrasound in the second trimester 
of the pregnancy (Allan et al. 1986). 
 
The fetal heart appears somewhat different than an adult heart. As a consequence of the 
normal large liver in fetal life, the heart is positioned more horizontally and the apex is 
displaced more cranially than in the adult. This results in a slightly different orientation 
of the heart with the right side positioned anteriorly in the fetal chest and the left side 
posteriorly. The two ventricles are equal in size in the fetus, and there is normally a 
patent foramen ovale between the two atria and a patent ductus arteriosus between the 
main pulmonary artery and the aortic isthmus. Fetal lungs are filled with water, which 
makes the heart visualized in planes not obtainable after birth (Allan et al. 1980, Allan 
1986). 
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Since most fetuses with CHD are found in non-selected populations, the ultrasound 
examination for screening purposes is the only opportunity to detect the majority of 
CHDs. For this reason, an easy way of examining the fetal heart during the routine 
examination was introduced in the mid 1980s (Fermont et al. 1985, Allan et al. 1986b). 
Among the eight scan planes Allan et al. (1980) investigated, the four-chamber view 
was one of the easiest views to obtain, thus the four-chamber view was the plane chosen 
to be obtained in every fetus at the routine scan. 
 
Table 1  Sonographic details from the four-chamber view. 
 Details obtained 
Transverse abdomen 
 
 
Abdominal aorta and 
inferior vena cava 
• Stomach is on the left side of the abdomen 
• Aorta is on the left side of the spine 
• Inferior vena cava is on the right side of the spine, ventral to the 
aorta 
The atrio-ventricular 
junction 
(The four-chamber view) 
 
 
Position 
 
 
 
 
 
Apical view 
 
 
 
 
 
Subcostal view 
• The heart occupies 1/3 of the thoracic area 
• The position is in the middle of the thorax with the apex 
pointing towards left 
• The rhythm is regular between 120–160 beats/minute. Short 
periods of bradycardia are normal in the second trimester of the 
pregnancy. 
• There is equal contractility on the left and the right side of the 
heart 
• There are two atria of equal size 
• There are two ventricles of equal size 
• The left ventricle forms the apex 
• The moderator band is found in the right ventricle 
• There are two atrioventricular valves 
• The tricuspid valve is closer to the apex than the mitral valve is 
• The two septa and the atrioventricular valves form an “offset 
cross” in the middle of the heart 
• There is an intact ventricle septum 
• There is a patent foramen ovale in the atrial septum 
• Two pulmonary veins connect to the left atrium 
 
The four-chamber view seemed to be an easy view to obtain, as the reported success 
rates in viewing the four chambers in all fetuses were more than 95% (Copel et al. 
1987, Achiron et al. 1992, Todros et al. 1997). Despite the easy access to this view, it 
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seemed to increase the detection rate of major CHDs to only a small degree (Achiron et 
al. 1992, Ott 1995, Tegnander et al. 1995, Todros et al. 1997). 
 
The importance of evaluating all the details in the four-chamber view, as shown in 
Table 1, has been emphasized by several authors (Allan 1986, Chaoui 2003, Sharland 
2004). 
 
To be able to detect CHDs with a normal four-chamber view the great arteries need to 
be included into the fetal heart examination. Educational sites and organizations 
recommend examination of both the four-chamber view and the great arteries when the 
fetal heart is evaluated. Details to evaluate when the great arteries are obtained are 
shown in Table 2. In 1997, Yoo et al. introduced the three-vessel view as an easy way 
to examine the great arteries (Table 2). The three-vessel view has proven to be an 
important view for detection of defects affecting the outflow tracts and the great arteries 
(Yoo et al. 1999, Gardiner 2001). 
 
Table 2  Sonographic details from the great arteries. 
 Details obtained 
The ventriculo-arterial 
junction 
 
 
Ascending aorta 
 
 
Pulmonary artery 
 
 
Three-vessel view 
• The ascending aorta arises from the left ventricle 
• There is continuity between the anterior wall of the ascending 
aorta and between the ventricle septum and the posterior wall 
and the mitral valve 
• The main pulmonary artery arises from the right ventricle and 
branches into the right pulmonary artery and the ductus 
arteriosus 
• The main pulmonary artery crosses over with the ascending 
aorta 
• The two arteries are approximately equal in diameter (the main 
pulmonary artery slightly larger) 
 
Three-vessel view 
• The main pulmonary artery is seen in a longitudinal view from 
the right ventricle to the ductus arteriosus 
• The ascending aorta is seen in a transverse view on the right 
side of the main pulmonary artery 
• The superior vena cava is seen in a transverse view on the right 
side of the ascending aorta 
• The vessels are arranged in a straight line and sized in 
decreasing order 
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When the great arteries were introduced, the heart examination also included the aortic 
arch and the ductal arch (Bromley et al. 1992). Details of importance to notice when the 
arches are examined are shown in Table 3. Later, a five-step approach to the  
examinations of the fetal heart was 
introduced including only transverse 
views from the fetus (Yagel et al. 
2001). The authors concluded that a 
proper evaluation of all the five views, 
also shown in Tables 1 and 2, make the 
view of the arches unnecessary. As the 
arches might be difficult to obtain due 
to the fetal position, the three-vessel 
view has been recommended as an 
optional view (Chaoui 2003a). Prenatal 
detection of ductal dependent CHDs 
may also improve from the effort of 
obtaining the three-vessel view (Viñals 
et al. 2002). 
 
Table 3  Sonographic detail of the aortic arch 
and ductal arch. 
 Details obtained 
The arches 
 
 
Aortic arch 
 
 
Ductal arch 
• The aortic arch is seen as 
a tight hook (“candy 
cane shape”) tucking into 
the center of the heart 
• The aortic arch gives rise 
to the head and neck 
vessels 
• The ductal arch arises 
from the right ventricle 
close to the anterior chest 
wall, is directed straight 
backwards (“hockey 
stick shape”) and 
connects to the 
descending aorta 
• The ductal arch have no 
head and neck vessels 
 
In a screening situation, the time allocated for the complete scan is limited. With an 
awkward fetal position or fetal movements, planes expected to be identified during the 
scan may not be obtainable. A higher detection rate of cardiac structures may be 
achieved if unlimited time is given for the examination (Allan et al. 1980) or if a repeat 
scan is offered when the fetal heart examination at the routine scan is difficult (Allan et 
al. 1980, Rustico et al. 1995, Kirk et al. 1997). For other fetal anatomical structures, the 
specific focus and standardization of the examination procedure, for instance nuchal 
translucency measurement at an early gestation, has resulted in an increased detection of 
certain developmental disorders (Nicolaides et al. 1992, Hafner et al. 1998a, Nicolaides 
1999, Schwärzler et al. 1999a, Souka et al. 2001, Hyett 2002). Had the same high 
quality standard used in the nuchal translucency measurements been applied to the 
  
 34 
evaluation of the four-chamber view and the great arteries, our detection rate of CHDs 
most likely would have been improved. 
 
Fetal echocardiography is defined as a specific fetal heart examination where the four-
chamber view, the great arteries and the venous return to the heart are evaluated (Huhta 
and Rotondo 1991, Stümpflen et al. 1996). To optimize the image of the heart, 
additional techniques such as spectral Doppler, color Doppler (Chaoui 2001) and even 
3D ultrasound (Budorick and Millman 2000, DeVore et al. 2003) may be used. 
Advanced techniques may well be of diagnostic value for the selected group of fetuses 
where a heart defect is suspected. For routine use in a screening situation, the use of 
advanced techniques is time consuming and requires skilled personnel. Until the views 
of the four chambers and the great arteries are properly learned and interpreted among 
the personnel performing routine fetal examinations, the advanced technology belongs 
in a fetal echocardiography setting. 
 
Teaching and training obstetric ultrasound 
In the early days of diagnostic ultrasound development, the static scanners were huge, 
bulky machines and required extremely skilful operators. As a consequence the average 
physician did not give much attention to the ultrasound technique (Eik-Nes 1993, Woo 
2005). The obstetrician and gynecologist Alfred Kratochwil, an enthusiast in obstetric 
ultrasound development, saw the need for training and offered courses in ultrasound in 
Vienna, starting in 1968. This was after the introduction of the articulated-arm design, 
which made the ultrasound machines easier to manipulate (Woo 2005). The same year 
Kratochwil published his first book “Ultraschalldiagnostik in Geburtshilfe und 
Gynäkologie”, one of the earliest textbooks in ultrasonography in this field (Kratochwil 
1968). Kratochwil has followed up his teaching tradition and, after his retirement in 
1992, started regular courses for 3D ultrasound. 
 
In the mid-1970s, the machines became easier to use with improved image quality. 
Since then, the ultrasound technique has gone through extensive improvement, both 
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when it comes to quality, size and cost of the machines. Ultrasound equipment is now 
available to all physicians. However, because modern ultrasound machines are highly 
developed technology with detailed resolution of the images and applications for 
different examination procedures, an understanding of the basic principles of ultrasound 
physics is a prerequisite for a proper and safe use of the equipment and an optimal 
ultrasound examination. 
 
The educational and training aspect regarding the use of obstetric ultrasound has 
become increasingly more important with the improvement in ultrasound technology. 
Still, the requirements regarding ultrasound education and training vary greatly. With 
the introduction of routinely performed ultrasound scans in pregnancy, the need for 
ultrasound operators suddenly increased. It was emphasized that the ultrasound 
operators needed ultrasound training and experience, but there were no requirements for 
such training and thus no quality control of the examinations was carried out (Backe 
and Buhaug 1986). 
 
The need for professions other than physicians to perform ultrasound examinations soon 
became obvious as the indications for the use of ultrasound in obstetrics increased. 
Already in the mid-1960s, nurses and radiographers assisted physicians in performing 
ultrasound examinations (Baker 2005). Approved by the American Institute of 
Ultrasound in Medicine, the American Society of Ultrasound Technical Specialists was 
established in 1970. After 10 years of discussions and struggling to survive as a 
profession, the first accreditation of educational programs occurred in 1982 (Baker 
2005). The term ’sonographer’ came to be used for this profession. Today, postgraduate 
ultrasound programs for sonographers are well established in several countries, such as 
the USA, Canada, Australia and the United Kingdom. 
 
In the department of Obstetrics and Gynecology in Malmö, Sweden, where the routine 
scans were originally introduced in 1976, the scans were performed by nurse/midwives 
(Grennert et al. 1978). In the Scandinavian system, nurse/midwives have a strong 
tradition in pregnancy care, and it was therefore natural to base the scanning on this 
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profession. This was immediately adopted in Norway. In Ålesund, a number of 
midwives were systematically trained in obstetric ultrasound by Eik-Nes in the early 
1980s. In Denmark, registered nurses initially took an interest in obstetric ultrasound, 
while nurse/midwives became involved at a later stage. For many years, obstetric 
ultrasound has been performed by personnel with varied ultrasound experience. In 1997, 
postgraduate education in obstetric ultrasound for nurse/midwives was established at the 
National Center for Fetal Medicine in Trondheim and is now part of the general offer of 
education at the Norwegian University of Science and Technology in Trondheim. This 
one-year part-time education includes both academic and clinical education and is at 
present the only education of this kind in Scandinavia. 
 
Ultrasound imaging is not a passive activity but rather an interactive process involving 
the sonographer, patient, transducer and the ultrasound instrument (Kremkau 2006). The 
ultrasound operator has to interpret the images while the examination is being 
performed, placing strong demands on the ultrasound operator’s knowledge and 
experience in ultrasound technique and interpretation of ultrasound images. The 
importance of experience has clearly been demonstrated in the RADIUS study where 
the poor detection rate of developmental disorders most likely was a result of poor 
training and not a result of the diagnostic limitations of the ultrasound technique 
(Ewigman et al. 1993, Gonçalves and Romero 1993, Crane et al. 1994). Studies also 
show that tertiary centers have higher detection rates of fetal malformations than do 
non-tertiary centers. This is most likely due to the academic environment and a higher 
number of examinations resulting in increased ultrasound skills (Saari-Kemppainen et 
al. 1990, Crane et al. 1994, Wong et al. 2003). Other studies show the success in 
implementing teaching programs for the detection of fetal malformations (Sharland and 
Allan 1992, Hunter et al. 2000, Carvalho et al. 2002, Cuneo et al. 2004), emphasizing 
that the basic training has not been sufficient. Ultrasound societies and educational sites 
have guidelines for the proper way of examining the fetus (Meyer et al. 1990, ISUOG 
education committee 1996, Burr and Johanson 1998, Abuhamad et al. 2004, Allan et al. 
2004, ISUOG guidelines 2006). These are of great value for the harmonization of the 
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examinations between countries, but may not reach their expectations as long as the 
basic ultrasound education insufficient. 
 
With the rapid development of ultrasound technology, new techniques and examination 
procedures have been introduced in obstetric ultrasound. This implies that the 
appropriate way of performing ultrasound examinations a few years ago has changed 
and may be different and improved today. Regular updates are necessary to keep up 
with the development, and each ultrasound operator carries this responsibility. Interest 
and motivation have been reported as important factors when it comes to applying new 
ultrasound techniques (Roberts et al. 1995, Nicolaides 2004). 
 
As long as governments and professional societies do not understand the necessity of 
ultrasound education, we have to accept that the quality of the examinations will vary, 
resulting in a variable quality of the scan offered to the pregnant population. Thus, the 
intention stated 20 years ago in the Consensus Statement from 1986 (Backe and Buhaug 
1986) about improvement of the quality of the examinations conducted, has not yet 
been fulfilled for the total pregnant population in Norway. 
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AIMS OF THE STUDIES 
One of the purposes of the second trimester routine ultrasound examination is to detect 
fetal developmental disorders that will benefit from prenatal diagnosis. Already in the 
late 80s it was clear that CHDs were detected far less frequently than defects in other 
fetal organs (Lys et al. 1989, Rosendahl and Kivinen 1989, Brocks and Bang 1991). To 
increase the prenatal detection rate of congenital heart defects, the present study has 
evaluated different methods to examine the fetal heart during the second trimester 
routine examination. An important factor was to find easy ways to examine the heart, as 
the fetal heart examination is only a small part of the complete routine scan. At the same 
time, the aim was to get as much information as possible from the heart to correctly 
differentiate normality from pathology. In addition to evaluating the sonographic 
appearance of the fetal heart, this study also addressed the sonographer/midwives’ 
scanning skills to see if their amount of experience affected their ability to obtain fetal 
heart structures, and thus affected their ability to detect heart defects. It was also of 
interest to follow the outcome of the CHDs, detected and not detected prenatally, to 
measure the impact of prenatal diagnosis of CHDs. 
 
The aims of the five studies were: 
I To assess if incorporation of the four-chamber view of the fetal heart was 
achievable within the 30 minutes allocated to the second trimester routine 
examination at 18 weeks of gestation, and to evaluate any fetal, maternal or 
technical reasons for not being able to obtain this view. 
 
II To evaluate prospectively whether the implementation of the four-chamber view 
to the second trimester routine examination in a large non-selected population 
would improve the detection rate of congenital heart defects compared to a period 
when the heart was not systematically evaluated, and to evaluate the CHDs 
detected and not detected to find ways to further improve the prenatal detection 
rate. 
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III To evaluate the detection rate of congenital heart defects in a non-selected 
population following the introduction of the four-chamber view and the great 
arteries to the second trimester routine scan, to understand the pattern of prenatal 
recognition of heart defects to further improve the detection rate, and to follow the 
fetuses/children with CHDs into the postnatal period to get a better understanding 
of the outcome, in order to improve the accuracy of counseling. 
 
IV To compare the experienced and the less experienced sonographer/midwives’ 
ability to obtain fetal heart structures leading to detection of CHDs at the second 
trimester routine scan in a large non-selected population with the purpose of 
evaluating whether basic education and experience, as opposed to advanced 
examination procedures, was of importance in detecting CHDs, and to suggest 
improvements to the current ultrasound training program. 
 
V To introduce a new three-dimensional technique based on tissue Doppler gating 
(TDOG) to create reconstructed, dynamic 3D ultrasound images of the fetal heart 
and to evaluate the accuracy of the signals and the reconstruction of the most 
common two-dimensional views used during a fetal heart examination. 
  
 40 
MATERIAL AND METHODS 
Populations and study design 
The non-selected population came from a geographically well-defined area including 
the city of Trondheim and eight surrounding communities with approximately 200,000 
inhabitants (Figure 15). 
 
Figure 15  Communities included in the study: 
1 Klæbu 
2 Malvik 
3 Melhus 
4 Midtre Gauldal 
5 Rissa 
6 Selbu 
7 Trondheim 
8 Tydal 
9 Åfjord 
 
This area is served solely by Trondheim University Hospital for all health care services. 
To ensure a true non-selected population, a community was included only when more 
than 97% of the pregnant women residing in the selected community received a prenatal 
ultrasound at the National Center for Fetal Medicine and more than 97% delivered at 
the University Hospital. The University Hospital also includes the only Neonatal 
Intensive Care Unit and the only Pediatric Cardiology Unit for the same population. 
 
During the study period from August 1986 to December 2001, this non-selected 
population constituted the total population of 42,381 fetuses, all scheduled to be born at 
Trondheim University Hospital. Of those, 41,354 (98%) had an ultrasound examination 
performed at the National Center for Fetal Medicine, and thus formed the study 
population (screened population). 
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1 
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The second trimester routine ultrasound examinations were scheduled at 18 completed 
weeks based on the last menstrual period and/or early clinical assessment. The 
examinations were performed mainly by nurse/midwives with basic training in obstetric 
ultrasound. Following the official university-based education in obstetric ultrasound 
they are referred to as sonographer/midwives. Ultrasound examinations prior to the 
routine scan were done by physicians with ultrasound experience, while normal follow-
up ultrasound examinations after the routine scan were mainly performed by 
sonographer/midwives. Except for the routine scan, the ultrasound examinations were 
performed on clinical indications, only. 
 
The routine fetal examinations were scheduled at 30-minute intervals, and included a 
basic obstetric history as well as general information to the parents. The ultrasound 
examination comprised assessment of the number of fetuses, regular biometric 
measurements, placental location, a detailed survey of the fetal anatomy and an 
overview of the adnexae uteri. The final gestational age was based on the fetal BPD 
between 16+1 and 22+5 weeks (BPD outer-outer 38–60 mm) or the BPD and/or CRL 
for those detected prior to the routine examination. All data from the ultrasound 
examinations were prospectively registered in a computer database. 
 
When a heart defect was diagnosed or suspected, a physician at the center carried out a 
detailed survey of the heart and the fetal anatomy, in most cases in the presence of a 
pediatric cardiologist. 
 
A perinatal team consisting of an obstetrician, a sonographer/midwife, a pediatric 
cardiologist and a social worker supported the parents and the fetus/newborn from the 
time of diagnosis until after the delivery. If the pregnancy was continued, a specialist 
pediatric cardiac nurse became a part of the perinatal team. When immediate 
intervention after birth was expected, the planned delivery took place at the National 
Hospital in Oslo where neonatal cardiac surgery service is centralized in Norway. If a 
pregnancy was terminated, the parents were supported during that process and during 
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the time thereafter. In Norway, termination of the pregnancy may be approved until 
approximately 22 weeks. 
 
Within the first 24 hours after birth, all newborns had a general clinical examination by 
a pediatrician. If a heart defect was suspected, the child was referred to a pediatric 
cardiologist for an echocardiogram. CHDs detected after discharge from the hospital 
were referred to the Pediatric Cardiology Unit. The health care program in Norway 
ensures all children regular physical examinations at child health care centers until 
school age. For the first part of the study these examinations took place at 3, 6 and 
12 months, and at 2, 4 and 7 years of age (Paper II), the examinations were later 
changed to 6 weeks, 6 and 12 months, and at 2, 4 and 6 years of age (Paper III). 
 
Paper I 
Incorporating the four-chamber view into the second trimester routine 
examination 
The prospective study included 7,322 consecutive fetuses at the second trimester routine 
examination and was divided into two periods: Period I, from June 1988 to May 1989, 
included 2,993 fetuses; Period II, from June 1989 to September 1990, included 
4,329 fetuses. The criteria for a proper four-chamber view were: two ventricles of equal 
size; two atria of equal size; the heart occupying one-third of the thorax area; the heart 
located in the middle of the thorax with the apex pointing to the left anterior chest wall. 
 
The five sonographer/midwives’ ability to include the four-chamber view into the 
second trimester routine protocol was assessed during Period II. Every fetus for which a 
four-chamber view could not be obtained was registered on a separate form with a 
comment about any reason why a proper image of this view failed. 
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Paper II 
Prenatal detection of CHDs at the second trimester routine examination including 
the four-chamber view of the fetal heart 
The prospective study included a total population of 12,232 fetuses, of which 11,894 
(97%) fetuses had a second trimester routine ultrasound examination and constituted the 
study population (screened population). The study was divided into two phases: Phase I, 
from August 1986 to May 1988, included 4,435 fetuses; Phase II, from June 1988 to 
January 1991, included 7,459 fetuses. The criteria for a proper four-chamber view were: 
two ventricles of equal size; two atria of equal size; the heart occupying one-third of the 
thorax area; the heart located in the middle of the thorax with the apex pointing to the 
left anterior chest wall. 
 
The detection rate of CHDs at the second trimester routine examination and a total 
prenatal detection rate was compared between Phase I, when no specific attention was 
paid to the fetal heart, and Phase II, when the four-chamber view was obtained in every 
fetus. The longest and shortest postnatal follow-up times for Phase I were 77 months 
and 58 months, for Phase II, 57 and 26 months, respectively. 
 
Paper III 
Prenatal detection of CHDs including the four-chamber view and the great arteries 
of the fetal heart – detection rates and outcome 
The prospective study included a total population of 30,149 fetuses, of which 29,460 
(98%) fetuses had prenatal ultrasound and constituted the study population (screened 
population). The study period lasted from February 1991 to December 2001. The 
criteria for obtaining the four-chamber view and the great arteries properly were: two 
atria of equal size; two ventricles of equal size; moderator band in the anterior right 
ventricle; tricuspid valve closer to apex than the mitral valve; intact ventricle septum; 
crossing of the ascending aorta with main pulmonary artery; aortic arch; ductal arch. 
From January 1995, a new scan was offered at approximately 20 weeks of gestation if a 
proper four-chamber view had not been seen at the routine scan. The examination at 
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20 weeks included the four-chamber view, the great arteries and the venous return to the 
fetal heart. 
 
The postnatal follow-up of the children born with CHD included a description of their 
clinical condition. A classification system has been developed to critically evaluate the 
use of diagnostic procedures and therapies in the management of prevention of disease 
states (American Heart Association, 1994). The functional capacity is based on 
subjective symptoms as well as objective assessment (Bennett et al. 2002). According 
to the New York Heart Association classification system, “healthy” was defined as a 
person with cardiac disease without limitations of physical activity or objective 
evidence of cardiovascular disease (Class I). 
 
The detection rate of CHDs was assessed after the four-chamber view and the great 
arteries of the fetal heart were included in the fetal examination protocol; the pattern of 
prenatal recognition was sought to further improve the detection rate, and CHDs were 
followed-up into the postnatal period to improve the accuracy of counseling. The 
children were followed for a minimum of two years and a maximum of 13 years. 
 
Paper IV 
Comparison between experienced and less experienced sonographer/midwives in 
obtaining fetal heart structures and detecting CHDs prenatally 
All sonographer/midwives assessed during the study period were specially trained in 
obstetric ultrasound. The basic training included a minimum of 200 routine 
examinations supervised by experienced sonographer/midwives in addition to a Level I 
ultrasound course. For this study, “experienced” was defined as a sonographer/midwife 
who had performed more than 2000 routine examinations after completing the basic 
ultrasound training. “Less experienced” was defined as a sonographer/midwife who had 
performed between 200 and 2000 routine ultrasound examinations after completing the 
basic ultrasound training. The ultrasound experience following the basic training varied 
from 3 months to 17 years. 
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The prospective study included a population of 29,460 fetuses, of which 29,035 (99%) 
had had a second trimester routine examination performed by a sonographer/midwife. 
Those who did not receive a second trimester routine scan and those who were scanned 
by a physician were excluded. During the study period from February 1991 to 
December 2001, the four-chamber view and the great arteries were obtained from the 
fetal heart. During the first five years of the study period, heart structures obtained from 
every fetus were registered in detail on a separate form: four chambers; intact 
ventricular septum; tricuspid valve closer to the apex than mitral valve; ascending aorta; 
main pulmonary artery; aortic arch; ductal arch. From January 1995, a new scan was 
offered at approximately 20 weeks if a proper four-chamber view had not been seen at 
the routine scan. The examination at 20 weeks included the four-chamber view, the 
great arteries and the venous return to the fetal heart. Minor CHDs were excluded from 
this study. 
 
A comparison between the experienced and the less experienced sonographer/midwives 
was carried out regarding their success rate in obtaining the fetal heart structures and 
prenatal detection of major CHDs. 
 
Paper V 
Introduction of three-dimensional ultrasound imaging of the fetal heart (TDOG) 
The study included 8 selected pregnant women who were scheduled for a regular 
cardiac scan between 20–24 gestational weeks following a second trimester routine 
examination. The scanning time was 30 minutes for each fetus. Tissue Doppler data 
from the fetal heart were used to calculate a gating signal to create dynamic 3D 
reconstruction of the heart. The classical 2D views for reconstruction were: four-
chamber view; ascending aorta; main pulmonary artery; three-vessel view; short-axis 
view of the great arteries; aortic arch; ductal arch; long-axis view of inferior and 
superior venae cavae. 
 
A new method to image the fetal heart was introduced. Tissue Doppler gated (TDOG) 
dynamic 3D ultrasound images of the fetal heart were created, the accuracy of the 
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TDOG signals and the reconstruction of the most common views through the fetal heart 
were evaluated. 
 
Methods 
Classifications of congenital heart defects 
In Paper II the heart defects were classified as critical or non-critical, in Papers III and 
IV as major or minor, which were synonymous to critical and non-critical. The 
difference in terminology was due to improved postnatal treatment over time, leading to 
survival of children with critical CHDs that in the early study period had had no 
treatment options. The classification was done retrospectively after a final diagnosis 
was achieved either by postnatal echocardiogram or by autopsy. The majority of the 
spontaneous losses after 22 weeks were autopsied. A perinatal pathologist at the 
National Center for Fetal Medicine performed the postmortem examinations (Isaksen et 
al. 1999). When postnatal echocardiogram or autopsy was not available, the prenatal 
video recordings and hard copies were scrutinized to ensure the correct heart diagnosis. 
 
The defects were classified as major when surgical repair was most likely to be required 
because of gross structural complexity having functional significance (Mitchell et al. 
1971), e.g. TGA, HLHS, AVSD, coarctation of aorta, large VSD (Papers II–IV). Heart 
defects were classified as minor when no intervention was likely to be required, e.g. 
mild pulmonary stenosis, mild aortic stenosis, small VSD, small ASD (Papers II and 
III). If there was doubt as to whether a heart defect was major or minor, the defect was 
classified as major if intervention was actually needed during the first month of life. 
Excluded from this study were arrhythmias with a structurally normal heart, patent 
ductus arteriosus, atrial septal defects < 3 mm (Radzik et al. 1993) and absent inferior 
vena cava with azygos continuation. Rhabdomyomas were categorized as tumors and 
thus excluded as heart defects. 
 
Fetal karyotyping was offered in all prenatally detected cases. During the first 10 years 
of the study it was mainly performed by fetal blood sampling; later, by amniocentesis 
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and fluorescence in situ hybridization analysis (FISH) (Wakui et al. 1999). The 22q11 
microdeletion was not routinely checked during this study. When a karyotype was not 
obtained, it was considered as probably normal. 
 
The major CHDs were grouped as isolated in fetuses with a normal karyotype and 
absence of extra-cardiac malformations; as abnormal karyotype in fetuses with a 
chromosome aberration with or without extra-cardiac malformations; as associated 
malformations in fetuses with extra-cardiac malformations but a normal karyotype 
(Papers III and IV). The most common major CHDs (AVSD, TGA, HLHS, coarctation 
of aorta) were grouped as simple when additional cardiac defects were absent, e.g. TGA 
or AVSD; as complex when additional heart defects were present, e.g. TGA with 
associated single ventricle, HLHS with additional coarctation of aorta (Paper III). 
 
Ultrasound equipment and computer software 
The ultrasound scanners used during the total study period were replaced over time. For 
Papers I and II, a Hitachi EUB 40 ultrasound scanner with 3.5 or 5 MHz transducers 
and a Hitachi EUB 410 with a 5 MHz transducer (Hitachi, Tokyo, Japan) were used. 
For Papers III and IV the ultrasound scanners used were Hitachi EUB 415 and EUB 
6000 with 5 MHz and 3.5 MHZ transducers (Hitachi, Tokyo, Japan), VingMed CFM 
800 with a 5 MHz mechanical sector transducer and VingMed System Five with a 3.5 
MHz curvilinear transducer (Vingmed Sound, Horten, Norway). For Paper V, a Vivid 7 
scanner (GE Medical Systems) with a 1.5D probe with a frequency range of 2–5 MHz 
(Vingmed Sound, Horten, Norway) was used and the reconstruction was performed 
with the EchoPAC-3D software product (GE Medical Systems). 
 
3D imaging 
Data acquisition 
3D data were acquired by collecting several datasets in one sweep covering the 
complete heart for each fetus. Using a free-hand technique, the transabdominal scan 
plane was slowly tilted manually over a period of 8–20 seconds (20–50 cardiac cycles). 
  
 48 
The total angle of the sweep was estimated by recording a separate loop through the 
center of the heart, in the elevation direction of the sweep. Each dataset consisted of a 
duplex sector scan with a visible B-mode image and 2D tissue Doppler not visible 
during acquisition. Based on subjective evaluation of the clinical data, a second 
harmonic setup with a transmitting frequency of 2.5 MHz and a receiving frequency of 
5.1 MHz, an inter-beam distance of 0.3˚ and a data rate of 96 frames/second was chosen 
as an adequate trade-off between frame-rate and image quality. The tissue Doppler 
settings were adjusted to provide a small bandwidth, but the frame size and frame rate 
were the same, with transmitting and receiving frequencies of 2.4 MHz and an inter-
beam distance of 3.8˚. There were three pulse firings in each beam direction of the 
tissue Doppler. 
 
The gating signal was derived from clutter-filtered IQ data. Following calculation of 
autocorrelation of lag 1, the imaginary part of this was averaged over each frame, and 
then the local minima were extracted. 
 
Reconstruction 
The EchoPAC-3D software program converted the B-mode scan-lines into a sequence 
of voxel datasets, yielding a 4D dataset with temporal resolution equal to the B-mode 
frame rate and duration of one cardiac cycle. The 4D data were then visualized by two 
standard examination techniques for 3D medical imaging: 2D slicing and volume 
projection. 
 
Gating signal accuracy 
CW spectral Doppler from the umbilical artery was used to evaluate the accuracy of the 
TDOG signal, and was recorded simultaneously with the B-mode and tissue Doppler IQ 
data, but with a separate ultrasound system. The recordings were synchronized for 
offline analysis by simultaneously recording an independent signal on both ultrasound 
systems. The cycle lengths from the two methods were then compared and the variation 
in time delay between upstroke readings from the spectrum and the TDOG signal was 
examined. 
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The use of the tissue Doppler signal for synchronization was evaluated visually by 
running side-by-side consecutive cineloops. 
 
Statistical analysis 
The observed frequencies were tested for significance using the X2 (Chi-square) 
statistical test (Papers I and II). Groups were compared in 2x2 contingency tables using 
Pearson Chi-Square or Fisher’s exact test (Papers III and IV). The level of significance 
was set at p < 0.05. 
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RESULTS AND COMMENTS 
Paper I 
Incorporating the four-chamber view into the second trimester routine 
examination 
In period I, a four-chamber view could not be obtained in 220 (7%) of the 2993 fetuses 
scanned using a Hitachi EUB 40 ultrasound scanner. A significant difference was found 
in the number of four-chamber views not obtained when the 3.5 MHz and the 5 MHz 
transducers were compared, 35/131 (26.7%) and 185/2862 (6.5%), respectively (p < 
0.001). 
 
In period II, there was no difference in the number of four-chamber views not obtained 
with a 5 MHz transducer when the Hitachi EUB 40 ultrasound scanner used through 
period I was compared with a new Hitachi EUB 410 ultrasound scanner, 3.8% versus 
4.3%, respectively. When the results for the Hitachi EUB 40 scanner with a 5 MHz 
transducer were compared between Period I (6.5%) and Period II (3.8%), significant 
improvement was found (p < 0.001). 
 
The reasons why a four-chamber view could not be obtained were; unfavorable position 
of the fetus, poor imaging and maternal obesity. The main reason for not obtaining a 
four-chamber view utilizing the 3.5 MHz transducer was poor imaging (52%); for the 5 
MHz transducer, the main reason was unfavorable fetal position (64%). 
 
Figure 16  Four-chamber views not obtained for each 
gestational week at the second trimester routine scan. 
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Figure 16 shows the percentage of four-chamber views not obtained for each gestational 
week between 16 and 21 weeks. 
 
The five sonographer/midwives active in both periods significantly improved their 
ability to obtain a four-chamber view from period I to period II when a 5 MHz 
transducer was used. The individual results for not obtaining a four-chamber view 
varied from 3-10% in period I to 2-6% in period II (p < 0.001). 
 
Comments: 
The four-chamber view was introduced in the mid-1980s (Fermont et al. 1985, Allan et 
al. 1986b) with the purpose of increasing the prenatal detection rate of CHDs. At that 
time, most studies concerning the fetal heart came from selected populations. In one 
such study (Copel et al. 1987), it was suggested that a four-chamber view of the fetal 
heart should be obtained in more than 95% of the fetuses between 18 and 40 weeks. As 
these results were based on ultrasound examinations throughout the pregnancy in a 
selected population it was not obvious that the same results would be reached in a non-
selected population at an earlier gestational age. At our center, 98% of the pregnant 
population received a second trimester routine scan between 16 and 22 gestational 
weeks and the 30 minutes allocated to the complete consultation were already exhausted 
to serve other tasks.  
 
Our study showed that a four-chamber view could easily be incorporated into the 
second trimester routine scan at approximately 18 weeks, as this view was successfully 
obtained in 96% of the fetuses. The result was similar to findings published from other 
non-selected populations at that time (Achiron et al. 1992, Vergani et al. 1992) and 
could also be compared with results from selected populations (Copel et al. 1987). It is 
assumed that 50% of the major CHDs can be detected by evaluating the four-chamber 
view (Allan et al. 1986b, Cullen et al. 1992), thus, an incorporation of this view may 
increase the prenatal detection rate of heart defects. During this study period, 87% of 
the pregnant women in the total country of Norway accepted the second trimester scan, 
97% in the region served by Trondheim University Hospital (Nafstad and Backe 1989). 
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Incorporation of the four-chamber view to the routine scan protocol would thus cover 
most of the pregnant population with the possibility to detect 2/1000 major CHDs. 
 
During the two periods, there were significant improvements in obtaining the four-
chamber view. In Period I, the 5 MHz transducer was superior to the 3.5 MHz 
transducer in obtaining this view. This could be explained by the improvement in 
resolution when a higher frequency was chosen. The different reasons why a four-
chamber view could not be obtained may support this explanation. The main reason for 
not obtaining this view utilizing the 3.5 MHz transducer was poor imaging, which most 
likely was caused by poor resolution. In both Periods I and II, the main reason for not 
being able to obtain the four-chamber view with the 5 MHz transducer was fetal 
position. Thus, the reason was not dependent on the quality of the transducer. 
Obviously, the awareness of the ultrasound equipment and the choice of transducer are 
of significant importance when small fetal structures are to be imaged. As a 
consequence of the obvious difference between the transducers, the 5 MHz transducer 
was preferred for the total second trimester routine scan, as better resolution due to an 
increase in frequency was expected to affect the image of the fetal anatomy in general, 
and thus improve the overall quality of the routine scan (DeVore 1985, Kremkau 2006). 
 
A four-chamber view could not be obtained in 7% of the fetuses in Period I when a 
Hitachi EUB 40 ultrasound scanner with a 5 MHz transducer was utilized. With a new 
Hitachi EUB 410 scanner with the same transducer in Period II, 4% could not be 
obtained, an improvement that could be explained by a new and better ultrasound 
machine. Interestingly, the results for the Hitachi EUB 40 improved from 7% in Period 
I to 4% in Period II. Although the same machine and transducer were used, the results 
improved significantly. Also when evaluating the results for the 5 sonographer/ 
midwives active in both periods, significant improvements were found. The 
improvements may thus also be explained by a learning effect. When particular focus 
was set on the four-chamber view, the technique to obtain this view and the familiarity 
of the details in the four-chamber view would most likely improve over time (Sharland 
and Allan 1992). The relatively long learning curve to obtain the four-chamber view, 
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also found by Sharland and Allan (1992), may suggest that the examination of the fetal 
heart is difficult to learn in a second trimester routine setting. 
 
The gestational age seemed to be of significant importance for the success in obtaining 
the four-chamber view. Prior to 18 weeks, the number of four-chamber views not 
obtained were higher than at 18–21 weeks. Sharland and Allan (1992) also found that 
four-chamber views were obtained less frequently prior to 18 weeks than after 18 weeks 
of gestation. Several authors have shown a high ability to obtain the four-chamber view 
after 18 weeks, and some report the results up to 40 gestational weeks, but without 
specification for each week (Copel et al. 1987, Achiron et al. 1992). As the routine fetal 
examination preferably is done in the second trimester, an ultrasound scan at 18–20 
weeks performed with a 5 MHz transducer seems to be the optimal choices for the best 
results according to our data. The examiner’s ultrasound experience also needs to be 
considered when evaluating the success in obtaining the four-chamber view. 
 
Paper II 
Prenatal detection of CHDs at the second trimester routine examination including 
the four-chamber view of the fetal heart 
Detection of CHDs 
In Phase I, when no particular attention was paid to the fetal heart, 49 fetuses in the 
population of the 4435 scanned had a CHD. Of the 17 major CHDs, three (18%) were 
detected at 18 weeks of gestation. None of the 32 minor CHDs were prenatally detected. 
 
In Phase II, when the four-chamber view of the fetal heart was obtained, 90 within the 
population of the 7459 fetuses scanned had a CHD. Nine (39%) of the 23 major CHDs 
were detected prenatally: 6/23 (26%) at the second trimester routine scan and 3/23 
(13%) at later scans. 
 
Table 4 shows the major CHDs missed at the 18-week routine scan with respect to the 
expected four-chamber view presentation, including the three detected later in the 
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pregnancy. In three of the 17 cases missed at 18 weeks (VSD, overriding aorta; TOF; 
double aortic arch), an adequate four-chamber view could not be obtained due to poor 
imaging or unfavorable position of the fetus. In 7/17 (41%) cases, the routine scan was 
performed prior to 18 weeks of gestation. 
 
Table 4  Major CHDs not detected prenatally (including three detected later in the pregnancy) at the 
18 week examination with four-chamber view presentation in Phase II. 
 
CHD diagnosis 
 
n 
Normal four-chamber 
view expected 
AVSD (twin, trisomy 21) 1 no 
Coarctation of the aorta 2 yes 
Coarctation of the aorta, ASD 1 yes 
Common arterial trunk, large VSD* 1 no 
Coarctation of the aorta, DIRV, VSD, mitral stenosis* 1 no 
Double aortic arch 1 yes 
TOF 2 yes 
TGA 3 yes 
Pulmonary atresia, tricuspid atresia, VSD* 1 no 
Tricuspid atresia, pulmonary stenosis, VSD 1 no 
VSD, large 2 no 
VSD, overriding aorta (trisomy 18) 1 yes 
Total 17  
*CHD detected in the third trimester 
 
Among the 4% in which a four-chamber view could not be obtained at the second 
trimester routine examination, 3 fetuses with major CHDs were found (incidence 
10/1000 fetuses).  
 
Epidemiology 
To ensure complete epidemiological data for the total population, 2 newborns with 
minor CHDs from Phase I (muscular VSD; secundum ASD) and 2 from Phase II 
(muscular VSD; pulmonary artery stenosis), where the mothers had not attended the 
ultrasound program at all, were included. The incidences of congenital heart defects for 
the total population from Phases I and II were: 11/1000 fetuses and 12/1000 fetuses, 
respectively; for major CHDs 4/1000 and 3/1000 fetuses; for minor CHDs 7/1000 and 
9/1000 fetuses, respectively. 
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Isolated VSDs constituted 18/34 (53%) of the minor CHDs in the total population in 
Phase I, 50/69 (73%) in Phase II. The same numbers for the isolated secundum ASDs 
were 5/34 (14%) and 7/69 (10%), respectively. Within the first year of life, 50% of the 
isolated VSDs from Phase I and 70% from Phase II closed spontaneously. 
 
Chromosome aberrations and associated malformations 
Chromosome aberrations were found in 7/40 (18%) of the major CHDs in the total 
population from Phase I and II, in 6/103 (6%) among the minor CHDs. The 
corresponding numbers for CHDs with associated malformations and normal karyotype 
were 6/40 (15%) and 11/103 (11%), respectively. Chromosome aberrations and/or 
associated malformations were present in 7/12 (58%) of the major CHDs prenatally 
detected, and in 6/28 (21%) of those not detected (p = 0.03). 
 
Outcome 
Of the 12 fetuses with a major CHD detected prenatally during Phases I and II, 9 (75%) 
were born alive and 5 (42%) were alive after 2 years. Nine CHDs were detected prior to 
22 weeks when TOP was an option, and 3/9 (33%) chose to terminate the pregnancy 
(Trisomy 18, VSD, overriding aorta; Trisomy 21, AVSD; pulmonary atresia, single 
ventricle complete situs inversus). Of the 28 fetuses with CHD detected postnatally, 26 
(93%) were born alive, and 22 (79%) were alive after 2 years. One (4%) of the major 
CHDs from Phase II not detected prenatally was terminated due to prenatal findings of 
Trisomy 18. The heart defect, VSD and overriding aorta, was found during autopsy. 
One intrauterine death was due to associated malformations (hydrocephaly, bilateral pes 
equino varus, single umbilical artery) and the postductal coarctation of aorta was found 
during autopsy. 
 
Comments: 
Detailed structures from the fetal heart imaged by real-time two-dimensional ultrasound 
were reported as early as in 1980 (Allan et al. 1980, Kleinman et al. 1980). At that time, 
pregnancies at increased risk for CHD were offered fetal echocardiography (Callan et 
al. 1991, Allan et al. 1994). Since then we have learned that most fetuses and children 
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with CHD are born to mothers at no increased risk at all (Davis et al. 1990, Sharland et 
al. 1990, Callan et al. 1991, Allan et al. 1994). The second trimester routine 
examination, offered to most pregnant women, therefore seems like the best opportunity 
to detect most of the CHDs in the population. Subsequent studies have shown that the 
four-chamber view of the fetal heart can easily be obtained at this routine scan (Achiron 
et al. 1992, Vergani et al. 1992, Sharland and Allan 1992). 
 
Our study showed that the prenatal detection rate of major CHDs at the second trimester 
examination improved from 18 to 26% when the four-chamber view was obtained in 
nearly every fetus. Among the 4% where a four-chamber view could not be obtained 
due to poor imaging or unfavorable position of the fetus (Paper I), three major CHDs 
were found. At that time a rescan was not a part of the protocol when a four-chamber 
view was not obtained, unless there was a suspicion of a heart defect. Retrospectively 
we may conclude that these fetuses represented a high-risk group, as the incidence of 
major CHD among those 4% was 10/1000 fetuses compared to 4/1000 in the general 
population. Those CHDs would most likely have been detected with a follow-up, 
detailed scan; this would have increased the detection rate at the routine scan from 26% 
to 39%. 
 
In the early nineties, few studies reported detection rates of CHDs from non-selected 
populations. In two studies from low-risk populations (Achiron et al. 1992, Vergani et 
al. 1992) the prenatal detection rates of CHDs after implementation of the four-chamber 
view varied from 48–81%. Those studies differed with the present study in population 
selection, gestational age and duration of the routine scan, a rescan if the first failed and 
shorter postnatal observation time affecting the ascertainment of cases. These 
differences make the results difficult to compare. One study from a selected population 
reported a 92% sensitivity of the four-chamber view (Copel et al. 1987). However, one 
should be cautious comparing results from selected populations to non-selected 
populations, since results from selected populations are influenced by the high 
incidence of the disease. Despite the differences, a common finding for all the studies 
was the increase in prenatal detection of CHDs after the four-chamber view was 
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implemented to the fetal heart examination – which was the desired effect. One may 
conclude that a detailed evaluation of the four-chamber view is necessary to detect 
CHDs prenatally. 
 
Of the major CHDs missed at the routine scan (including the three CHDs detected 
later), 35% would be expected to have an abnormal four-chamber view at that time in 
the pregnancy (Table 4), thus a four-chamber view was interpreted to be normal when it 
obviously was not. Several studies have documented that the four-chamber view is 
difficult to obtain prior to 18 weeks in the pregnancy (Sharland and Allan 1992). In the 
present study, 41% of those missed had a routine scan at a gestation prior to 18 weeks, 
which might have affected the ability to interpret the four-chamber view correctly. Two 
of those scanned prior to 18 weeks (tricuspid atresia; coarctation of the aorta, DIRV) 
were detected at a later third trimester scan, which supports the experience that the four-
chamber view is easier to examine at a later gestation (Copel et al. 1987, Achiron et al. 
1992, Tegnander et al. 1994). As the routine fetal examination is a compromise 
accommodating the various reasons for performing such a scan we rather need to look 
at ways of improving the scan qualities than at changing the time of its performance. 
Also, the 22 week upper limit for termination of a pregnancy in Norway requires an 
anomaly scan prior to 20 gestational weeks. 
 
Evaluation of the four-chamber view can possibly only detect heart defects with an 
abnormal four-chamber view. CHDs such as TGA, TOF, DORV, mild pulmonary 
stenosis, mild aortic stenosis, and small VSDs will most likely appear with a normal 
four-chamber view and thus be missed. For this reason, the four-chamber view is 
expected to detect 50% of the major CHDs (Allan et al. 1986b, Cullen et al. 1992). 
Sharland and Allan (1992) excluded the CHDs with a normal four-chamber view and 
evaluated the detection rate of CHDs with an abnormal four-chamber view, only. They 
implemented a teaching program where ultrasonographers from ten obstetric ultrasound 
units were taught to obtain the four-chamber view. As a result of the teaching program, 
77% of the CHDs with an abnormal four-chamber view were prenatally detected. The 
percentage of four-chamber views not obtained decreased dramatically from 15-20% 
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and ended with less than 5% in most units. Finally, an increase was found in the number 
of CHDs detected prenatally because of suspected abnormal four-chamber views at the 
routine scan. Obviously, the teaching program had an impact on the way the four-
chamber view was evaluated. Still, 23% of the CHDs with an abnormal four-chamber 
view were not detected, emphasizing the difficulties in prenatal evaluation of this view. 
 
Our criteria for a proper four-chamber view were two ventricles of equal size; two atria 
of equal size; the heart occupying one-third of the thorax area and located in the middle 
of the thorax with the apex pointing toward the left anterior chest wall. In addition to 
those criteria, for their teaching program, Sharland and Allan (1992) also evaluated the 
two atrioventricular valves which meet the atrial and ventricular septa at the crux of the 
heart in an offset cross-appearance, the presence of the foramen ovale defect in the atrial 
septum and the appearance of an intact ventricle septum. As the present study reported 
the detection rate among all major CHDs in the population and Sharland and Allan 
(1992) among major CHDs with an abnormal four-chamber view, these results are 
difficult to compare. Still, one may speculate that requiring more details from the four-
chamber view forces the examiner to obtain a better image and thus makes it easier to 
detect CHDs. 
 
Chromosome aberrations and/or associated malformations were found in 32% of the 
major and in 16% of the minor CHDs. A high percentage of extra-cardiac 
malformations in CHDs has been reported by others (Berg et al. 1988, Copel et al. 
1988), and the importance of cytogenetic evaluation when a CHD is detected has been 
emphasized. The presence or absence of extra-cardiac malformations is important for 
the outcome and thus the counseling process.  
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Paper III 
Prenatal detection of CHDs including the four-chamber view and the great arteries 
of the fetal heart – detection rates and outcome 
Detection of CHDs 
Of the 29,460 fetuses scanned, 97 were found to have a major CHD, 333 a minor CHD. 
The incidences of major and minor CHDs were 3.3 and 11.3/1000, respectively, making 
an incidence of 14.6/1000 fetuses in the study population. Figure 17 shows the 
incidences of major and minor CHDs in the total population for the Phases I, II and III. 
 
Figure 17  Incidences of major and minor CHDs for each 
phase in the total population of 42,381 fetuses. 
 
 
Of the major CHDs, 55/97 (57%) were detected prenatally: 9/55 (16%) prior to, 36/55 
(66%) at, and 10/55 (18%) after the routine scan, respectively. Of all major CHDs in the 
study population, 45/97 (46%) were detected prior to 22 weeks.  
 
Figure 18  Major CHDs in a non-selected population of 41,354 
fetuses, detection rates and time of detection. 
 
 
1986-1988 1988-1990 1991-2001 
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Of the major CHDs classified as complex, 11/14 (79%) were detected prenatally 
compared to 22/40 (55%) of those classified as simple (p = 0.12). Figure 18 shows the 
percentages of major CHDs prenatally detected for the Phases I, II and III and the time 
of detection. 
 
Of the 9 fetuses with major CHD detected prior to the routine scan, 5 (56%) had an 
increased nuchal translucency or cystic hygroma. 
 
Six of the 10 major CHDs detected late in the pregnancy were missed at the routine 
scan, while four had a first scan at our institution after 29 weeks. Four (67%) of the 6 
missed would have had a normal four-chamber view at the 18-weeks scan (2 TOF; 
TGA; pulmonary valve stenosis). 
 
Isolated CHDs constituted 43/97 (44%) of all major CHDs in the study population, and 
19/43 (44%) were detected prenatally. Of the isolated CHDs, 23/43 (54%) were ductal 
dependent and 11/23 (48%) of those were detected. Of the 24 isolated CHDs missed 
prenatally, 14 (58%) would be expected to have an abnormal four-chamber view at the 
second trimester routine scan. 
 
Major heart defects with associated malformations or abnormal karyotype totaled 54/97 
(56%). Thirty-six (67%) of them were detected prenatally, a significantly better result 
compared to the number of major isolated CHDs detected prenatally (p = 0.03). 
 
Table 5  Incidences of isolated VSDs and isolated secundum ASDs per 
1000 fetuses for each phase in the total population. 
Study Population  Isolated VSDs   Secundum ASD  
phase N  n Incidence  n Incidence 
I 4,615  18 0.6  5 0.2 
II 7,617  51 1.6  7 0.2 
III 30,149  192 6.3  39 1.3 
Total 42,381  261 6.2  51 1.2 
 
Twelve (4%) of the 333 minor CHDs in the study population were detected prenatally. 
Of all minor CHDs, 188 (57%) were isolated VSDs and 38 (11%) were isolated 
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secundum ASDs. Table 5 shows the incidences of isolated VSDs and ASDs in the total 
population for Phases I, II and III. 
 
Abnormal karyotype and associated malformations 
Abnormal karyotype was found in 37 (38%) of the 97 major CHDs. Of the CHDs 
grouped as complex and simple, 2/14 (14%) and 21/40 (53%) had abnormal karyotype, 
respectively (p = 0.02). Among the 55 CHDs detected, 26 (47%) had an abnormal 
karyotype and 10 (18%) had associated malformations and normal karyotype. The 
corresponding numbers for the 42 major CHDs not detected prenatally were 11 (26%) 
and 7 (17%), respectively. A significant difference was found between the prenatally 
and postnatally detected major CHDs with associated malformations including 
abnormal karyotype (p = 0.03). Forty-five (82%) major CHDs were detected prior to 22 
weeks when termination of the pregnancy was an option. Among the 24/45 (53%) who 
opted for a termination, 21 (84%) had associated anomalies including abnormal 
karyotype, compared to 10/21 (48%) of those who continued their pregnancy (p = 0.01). 
Five (63%) of the 8 intrauterine fetal deaths had abnormal karyotype. 
 
Of the 333 minor CHDs, 27 (8%) had abnormal karyotype and 32 (10%) associated 
malformations. Of the 12 detected prenatally, all had abnormal karyotype or associated 
malformations. 
 
Outcome 
The outcomes of the major CHDs detected and not detected prenatally are shown in 
Figure 19. Intrauterine fetal death occurred in 8/55 (15%) of the fetuses with a major 
defect detected, but in none of the 42 fetuses with a major defect that was not detected 
(p = 0.01). When the terminated pregnancies were excluded, 23/31 (74%) of the fetuses 
with a major CHD detected prenatally were born alive compared to 41/41 (100%) of 
those not detected prenatally (p = 0.001). Of the children who survived until two years 
of age, all were still alive at a median follow-up of six (range 2-13) years. 
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Figure 19  Outcome of major CHDs in a non-selected population of 29,460 fetuses. 
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One of the 12 fetuses with a minor CHD detected prenatally was born alive with a 
possible genetic defect and a syndrome. 
 
Isolated ventricular septal defects without extra-cardiac malformations totaled 57% 
(188/333) of the minor heart defects. Of those, 162 (86%) were muscular and 26 (14%) 
were perimembranous. During the first year of life, 77/162 (48%) of the isolated 
muscular and 3/26 (12%) of the isolated perimembranous VSDs closed spontaneously. 
 
Comments: 
This study showed that inclusion of the great arteries to the fetal heart examination, in 
addition to the four-chamber view, increased the detection rate of major CHDs at the 
second trimester routine scan from 26% (Paper II) to 37%, and the total prenatal 
detection rate from 39% to 57%. 
 
The classification of CHDs seems arbitrary when comparing papers evaluating the 
prenatal detection of CHDs, making both detection rates and outcome difficult to 
compare (Cullen et al. 1992, Fernandez et al. 1998, Bull 1999, Jaeggi et al. 2001, 
Carvalho et al. 2002, Wong et al. 2003). Even among experts the definition of major 
CHDs seems to differ, although the majority seem to classify major CHDs as those that 
will require surgical or interventional treatment during the first year of life (Allan et al. 
2001). In addition, the evaluation of the severity of major CHDs has changed over time 
and should be seen in relation to the improvement in postnatal treatment and surgery. In 
the late-1980s, HLHS was considered a critical and lethal diagnosis and most parents 
chose to terminate the pregnancy after being counseled about treatment options (Allan 
et al. 1991). With improved surgical techniques (Jacobs et al. 1994) HLHS is no longer 
a CHD without option of postnatal treatment and is thus not considered lethal or critical 
(Andrews et al. 2001, Tworetzky et al. 2001, Wilkins-Haug et al. 2005). In line with the 
therapeutic improvements we renamed the two groups of CHDs from critical and non-
critical to major and minor, although the definition of the CHDs remained the same 
through the complete study period. 
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The study period extended over 11 years. During that time, advanced imaging 
techniques and diagnostic tools were introduced, making it easier to detect fetal 
developmental disorders at an early gestation (Blaas et al. 1999, Devine and Malone 
1999, Schwärzler et al. 1999a). Thus, the different use of prenatal tests makes studies 
evaluating the second trimester routine examination difficult to compare. The 11–13+6 
week nuchal translucency screening (Nicolaides et al. 1992) and the development of 
OSCAR-clinics (One-Stop Clinic for Assessment of Risk) (Nicolaides et al. 2002) 
result in early detection of major CHDs and consequently a lower incidence of CHDs at 
the time of the second trimester examination. In one study from a non-selected 
population, a fetal heart training program was carried out, resulting in a 38% detection 
rate of major CHDs at the second trimester routine scan (Carvalho et al. 2002). 
Although the result seems similar to ours, 80% of the women in their population had an 
early scan detecting 20% of the major CHDs which would affect the number of CHDs 
present at the second trimester scan. Our data also show the same trend. Although 
nuchal translucency screening is not an offer to the pregnant population in Norway, 9% 
of the major CHDs were detected prior to the routine scan, changing our previous 
pattern of prenatal detection of CHDs (Figure 18). 
 
The introduction of the four-chamber view to the fetal heart examination raised high 
expectations for the detection rate of major CHDs (Copel et al. 1987). As the detection 
rate from second trimester routine scans started to emerge, the results clearly did not 
meet the expectation of 50% detection (Allan et al. 1986b, Sharland et al. 1992) but 
rather between 4.5–48% from non-selected populations (Achiron et al. 1992, Ott 1995, 
Buskens et al. 1996, Todros et al. 1997). When these studies revealed that the four-
chamber view provided poorer results than anticipated, more details of the heart were 
included rather than question the methods of four-chamber view acquisition. 
Retrospectively, one may wonder if the potential of this view had been fully utilized 
(Chaoui 2003b). 
 
With both the four-chamber view and the great arteries included into the fetal heart 
examination, studies showed that total prenatal detection rates of major CHDs increased 
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to 40–83% (Achiron et al. 1992, Bromley et al. 1992, Hafner et al. 1998b, Carvalho et 
al. 2002, Wong et al. 2003). Our total detection rate of 57% was in accordance with the 
published data, but the detection rate at the second trimester routine scan, 37%, was still 
low. The details of the fetal heart are better imaged after 20 weeks (Schwärzler et al. 
1999b, Allan 2003), thus a scan after 20 weeks would probably make it easier to detect 
CHDs. With an early scan for nuchal translucency measurements, including dating of 
the pregnancy, an anomaly scan can be performed at a later gestation (Carvalho et al. 
2002). Since the 18-week routine scan still is the only ultrasound examination offered to 
all pregnant women in Norway, efforts have to be made to increase the detection rate of 
major CHDs at this scan. Also, the upper limit for termination of the pregnancy is 22 
weeks in Norway, thus CHDs need to be detected prior to 22 weeks to give the parents 
this option. 
 
Figure 18 shows data from a period ranging more than 15 years from our large non-
selected screened population of 41,354 fetuses and summarizes the prenatal detection of 
major CHDs through all the three Phases. Since 1986, all pregnant women in Norway 
have been offered one routine ultrasound examination in the second trimester (Backe 
and Buhaug 1986), and since then every second trimester scan at our center has been 
prospectively registered in our database. The data from this database clearly showed 
that the detection of major CHDs through 1986 and 1987 was poor, only 18% (Paper 
II). This was the time that the four-chamber view of the fetal heart was introduced, and 
during Phase II our target was to obtain a four-chamber view in all fetuses scanned. As 
we started to pay more attention to the fetal heart, the results improved and, as Figure 
18 shows, CHDs were even detected in the third trimester when ultrasound scans were 
done on indications only. An increase in the detection rate to 26% at the routine scan 
(Phase II) still left most of the major CHDs undetected. Encouraged by the 
improvement after implementation of the four-chamber view, we added the great 
arteries to the fetal heart examination to further increase the detection rate. In Figure 18, 
the improved detection rate as more details of the fetal heart were added to the 
ultrasound examination is clearly shown. The impact of the second trimester scan is 
emphasized here, since this is the time that most of the major CHDs were detected, and 
  
 66 
the changing pattern in prenatal detection of the defects was observed. The focus on the 
early scan has resulted in detection of CHDs prior to the second trimester scan, a change 
that now has to be addressed. Although the focus on the fetal heart examination through 
many years clearly has resulted in increased detection rates, Figure 18 shows that too 
many CHDs still are left undetected, clearly challenging our skill to organize and 
perform the fetal heart examination by ultrasound. 
 
To help in further improving the skills in fetal heart scanning, characteristic findings of 
the defects detected as opposed to those not detected were sought. When looking at our 
data, we found that we detected significantly more of the CHDs with abnormal 
karyotype and/or associated malformations than we detected isolated CHDs. This shows 
that extra-cardiac malformations seem easier to detect than defects in the heart itself. 
This has also been found by other investigators (Stoll et al. 2002). Only 44% of all 
isolated CHDs and 48% of the isolated ductal dependent CHDs were detected 
prenatally, leaving more than one half of the cases undetected. Since the heart is the 
only affected organ in those cases, we can conclude that the examination of the fetal 
heart most likely has not been sufficient. Of all the isolated CHDs, we detected 47% 
with a normal four-chamber view, but, 58% of those we missed were expected to have 
an abnormal four-chamber view. Thus, a true abnormal four-chamber view was 
obviously not always recognized. When detection of the complex and the simple CHDs 
were compared, we detected more of the complex CHDs where the defect was severe 
than the simple CHDs. This pattern seemed to favor the detection of the more serious 
defects. Convincing data today show that the outcome seems better for isolated CHDs 
compared to those with extra-cardiac malformations, especially when prenatally 
detected (Bonnet et al. 1999), thus, efforts have to be made to increase the detection of 
isolated CHDs. Overall, we may conclude that the fetal heart examination in general is 
not sufficiently mastered, and more focus has to be put on both the examination of the 
four-chamber view and the great arteries. 
 
Minor CHDs have been difficult to detect prenatally, especially as isolated defects 
(Allan et al. 1989). In our series, we did not detect minor CHDs in Phase I or II (Paper 
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II), but 12 (4%) minor CHDs were detected in the present study (Phase III). One may 
speculate whether improved ultrasound skills and knowledge over time have resulted in 
detection of those minor defects, or if it was the extra-cardiac malformations rather than 
the heart itself that was the reason for the detection (Hafner et al. 1998b). The real 
importance of detecting those minor CHDs may be questioned, unless they are 
associated with a chromosome aberration. 
 
Published data show a strong association between CHDs and extra-cardiac 
malformations (Copel et al. 1988, Schwanitz et al. 1990, Allan et al. 1994, Carvalho et 
al. 2002, Stoll et al. 2002), emphasizing the importance of cytogenetic evaluation when 
CHDs are prenatally detected (Berg et al. 1988, Paladini et al. 1993). In the present 
study, as much as 38% of the major CHDs had abnormal karyotype and 17% associated 
malformations and normal karyotype. One large population-based study, the Baltimore-
Washington Infant Study, found only12% chromosome aberrations among live born 
infants (Ferencz et al. 1989). As we know that fetal populations include stillbirths and 
terminations of pregnancies where the incidence of CHDs associated with extra-cardiac 
malformations is high (Chinn et al. 1989, Tennstedt et al. 1999), a comparison between 
a fetal and an infant population will not be correct (Allan et al. 1994). When the results 
from the Baltimore-Washington Infant Study were adjusted for the effect of intrauterine 
lethality, the risk of aneuploidy for a fetus detected with CHD at the routine scan was 
found to be close to 40% (Berg et al. 1988), which is in accordance with the findings 
from the present study. Our data also showed a significantly higher association of 
chromosome aberrations among simple CHDs compared to complex CHDs, 
emphasizing the importance of detecting those simple CHDs. The results challenge our 
ultrasound skills as we detected significantly more of the complex than the simple 
CHDs. 
 
The tendency to detect the most severe CHDs prenatally also reflects the outcome 
(Montaña et al. 1996, Boldt et al. 2002). As shown in Figure 19, the outcome was 
significantly better for the children where the heart defect was detected after birth, 
which supports previous findings (Allan et al. 1994, Bull 1999). The significantly 
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higher number of associated malformations and/or abnormal karyotype among the 
prenatally detected CHDs emphasizes the seriousness of those defects. The risk for 
spontaneous intrauterine death has been shown to increase in chromosomally abnormal 
fetuses (Hoffman 1995b). The fact that intrauterine fetal death occurred in 15% of the 
fetuses with a CHD detected prenatally (of which 63% had a chromosome abnormality), 
compared to zero fetal deaths among the postnatally detected, underlines the difference 
in seriousness between these two groups also in the present study. The same tendency 
was found among the terminated pregnancies where 58% of the fetuses had associated 
lethal chromosome aberrations or had developed a life-threatening condition at an early 
gestational age, and the rest, except for the Trisomy 21 cases, were severe anomalies 
requiring major surgery.  
 
During recent years the prenatal detection of CHDs has improved and a trend towards 
more survivors has been found (Copel et al. 1997, Bonnet et al. 1999, Tworetzky et al. 
2001, Brick and Allan 2002, Franklin et al. 2002). Those findings are encouraging in 
our effort to further increase the number of prenatally detected CHDs. With new 
surgical options and results, the long-term follow up will be of importance to give the 
best possible counseling when a major CHD is detected at the routine scan (Allan and 
Huggon 2004). 
 
Despite years of persistent attempts to increase the prenatal detection rate at the second 
trimester routine examination, the fetal heart remains the most difficult organ to 
examine. Once prenatally diagnosed, the chance to survive until 2 years of age was only 
27%, compared to 81% for those who were not detected prior to birth. The difficulties 
in showing improved outcome in prenatally detected CHDs may reflect the nature of the 
fetal cardiac disease that often is severe and with associated malformations (Yates 
2004), as demonstrated in our study. Prenatal studies also tend to include those heart 
defects that have not been included in postnatal series because of death prior to surgery 
and a post-mortem diagnosis, influencing the outcome data (Abu-Harb et al. 1994, 
Yates 2004). In our effort to detect more of the major CHDs prenatally, we also need to 
focus on detecting these serious defects as early in the pregnancy as possible to allow 
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parents the choice of termination of the pregnancy (Allan and Huggon 2004). Also, 
when the pregnancy is continued, prenatal diagnosis will ensure optimal perinatal 
management and may influence the long-term morbidity (Eapen et al. 1998, Mahle et 
al. 2000, Yates 2004). 
 
The largest studies reporting on the incidence of CHDs from the 1970s and 1980s 
reported incidences between 8–9/1000 live births (Mitchell et al. 1971, Hoffman and 
Christianson 1978, Ferencz et al. 1985, Carlgren et al. 1987, Šamánek et al. 1989). 
Congenital heart disease is by definition cardiovascular disease present at birth, but the 
true postnatal incidence may be difficult to assess due to several factors, for instance 
unrecognized CHD in early infant deaths (Abu-Harb et al. 1994, Hoffman 1995a). With 
prenatal diagnosis of CHDs, termination of pregnancies will also affect the incidence in 
a live born population (Saari-Kemppainen et al. 1990, Allan et al. 1991). 
 
In fetal populations, the incidence of CHD is found to be higher than in live born 
populations (Rosendahl and Kivinen 1989, Hafner et al. 1998b). This may be due to the 
higher incidence of malformations in general in spontaneous abortions and stillbirths 
(Mitchell et al. 1971, Chinn et al. 1989). Figure 17 shows the increase in the overall 
incidence of CHDs in the present study from 11.1/1000 in Phase I to 14.7/1000 in 
Phase III. Interestingly, the incidences of major CHDs, 3–4/1000, were consistent and 
in accordance with the reported incidence of major CHDs (Ferencz et al. 1985). This 
emphasizes that the overall high incidences are not due to selection biases. The 
development of advanced ultrasound techniques has made it possible to detect minor 
CHDs today not detectable some years ago, either prenatally or postnatally. This is 
clearly demonstrated in Table 5 as both the incidence of isolated VSDs and ASDs have 
increased over time and are probably responsible for the increase in the incidence of 
minor CHDs during the last few years (Meberg et al. 1994, Roguin et al. 1995, Wren et 
al. 2000). It may be questioned whether these minor defects are true heart defects and 
not just a delay of a normal closure process towards the end of the pregnancy (Ben-
Shachar et al. 1985, Hiraishi et al. 1992). The fact that none of these children needed 
treatment and that approximately 50% of the isolated VSDs closed spontaneously after 
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birth, indicate that we are observing a physiological process rather than pathology 
(Radzik et al. 1993, Meberg et al. 1994, Roguin et al. 1995, Helgason and Jonsdottir 
1999). 
 
Paper IV 
Comparison between experienced and less experienced sonographer/midwives in 
obtaining fetal heart structures and detecting CHDs prenatally 
During the study period, 29,035 fetuses had a second trimester routine examination 
performed by a sonographer/midwife. There was no difference in the experienced and 
less experienced midwives’ ability to obtain the four-chamber view at the routine scan 
(97%). Significant differences were found when the ability to obtain the ascending aorta 
(85% and 66%, respectively), the pulmonary artery (78% and 36%, respectively) or 
both arteries (75% and 36%, respectively) was evaluated (p < 0.001). Figure 20 shows 
the ability to obtain both the four-chamber view and the great arteries over time for the 
five experienced sonographer/midwives and the four less experienced 
sonographer/midwives who were new in this work in 1991, 1993 and 1995. A 
significant increase in the ability to obtain both views were found among the new, less 
experienced sonographer/midwives during the period from 1991 – 1995. 
 
Figure 20  The ability to obtain the four-chamber view and the great arteries in 
2994 fetuses, over time, for the experienced sonographer/midwives and the less 
experienced sonographer/midwives who started in 1991, 1993 and 1995, respectively. 
 
 
* 
*p < 0.0001 
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Of the 82 major CHDs in the study population, 35 (43%) were detected at the routine 
examination. The experienced sonographer/midwives detected 22/42 (52%) and the less 
experienced 13/40 (33%) (p = 0.07). Of the CHDs grouped as isolated, the detection 
rates were 8/18 (44%) and 6/22 (27%), respectively (p = 0.26), and for the CHDs with 
associated malformations 14/24 (58%) and 7/18 (39%), respectively (p = 0.21). 
 
Of the 82 fetuses with a major CHD, 36 (44%) had a routine scan prior to 18 weeks. Of 
those, the experienced sonographer/midwives detected 11/22 (50%) of the CHDs 
prenatally, the less experienced 6/14 (43%). Of the 46 fetuses with a major CHD 
scanned after 18 completed weeks, the corresponding numbers were 11/20 (55%) and 
7/26 (27%), respectively (p = 0.05). 
 
Fifty-eight (71%) of the 82 major CHDs would be expected to have an abnormal four-
chamber view at the time of the routine scan. Of these, 34/58 fetuses were examined by 
experienced sonographer/midwives and 28 (88%) of the abnormal views were 
recognized. The corresponding number for the less experienced sonographer/midwives 
was 13/26 (50%) (p = 0.002). 
 
Of the isolated CHDs missed at the routine scan, 16/26 (62%) would be expected to 
have an abnormal four-chamber view: the experienced sonographer/midwives missed 
5/10 (50%) and the less experienced 11/16 (69%). In 3/47 (6%) of the major CHDs 
missed, the sonographer/midwives had suspected a malformation at the routine scan, but 
the finding was not interpreted as pathology by the consulted physician. Nineteen (40%) 
of the 47 CHDs missed had a routine scan prior to 18 completed weeks. 
 
Among the 19,237 fetuses scanned between 1995 and 2001, the percentage of fetuses 
with a four-chamber view not obtained at the second trimester routine examination 
decreased per year from 2.4% in 1995 to 1% in 2001. Unfavorable fetal position (41%) 
and poor imaging (40%) were the main reasons why the four-chamber view could not 
be obtained. 
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Comments: 
The recent advances in ultrasound technology have placed great responsibility on the 
ultrasound operator. The different ultrasound techniques allow the operator to examine 
the fetus in more detail and to survey the fetus in better ways than only a few years ago 
(Eik-Nes et al. 1982, Eik-Nes 1993b, Blaas 1999, Hofstaetter et al. 2002, Brantberg et 
al. 2004). Proper training is necessary to utilize the potential of the ultrasound machine 
and to keep up with the new information, techniques and the development in the field of 
obstetric ultrasound. 
 
Post-graduate ultrasound education and ultrasound courses are available in many 
countries, but are not mandatory for those who work with diagnostic ultrasound. With 
no requirements of education, it is the ultrasound operators’ responsibility to realize 
their own need for training. This has resulted in a large variation of background 
knowledge and experience among those working with obstetric ultrasound. Each 
sonographer/midwife in the present study received three months of basic ultrasound 
training, including a one-week basic theoretical course in addition to a minimum of 
200 ultrasound scans supervised by an experienced sonographer/midwife. 
 
The analysis of our results showed that 62% of the isolated major CHDs missed 
prenatally were expected to have an abnormal four-chamber view. Other studies also 
show that too many CHDs with an abnormal four-chamber view were missed (Wong et 
al. 2003). Although the detection rates increased when the great arteries were obtained, 
the detection rates did not reach the expected numbers for the four-chamber view alone 
(Stoll et al. 1998, Hunter et al. 2000). The lack of increase in the detection rate when 
more views were included into the fetal heart examination may indicate that other 
factors ought to be addressed. 
 
Our study showed that experience played a significant role when it came to obtaining 
the fetal heart structures. In the mid-eighties, when the four-chamber view was 
introduced (Fermont et al. 1985, Allan et al. 1986b), studies demonstrated that this view 
could easily be incorporated into the fetal heart examination at the routine scan as it was 
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obtained in more than 95% of the fetuses (Copel et al. 1987, Achiron et al. 1992, 
Vergani et al. 1992, Tegnander et al. 1994, Todros et al. 1997). The same tendency was 
found in the present study where the four-chamber view was obtained in 97% of the 
fetuses. No difference was observed between the experienced and the less experienced 
sonographer/midwives, thus the four-chamber view seemed like an easy view to obtain 
no matter the degree of experience. 
 
On the other hand, when we look at the isolated CHDs missed prenatally, 62% were 
expected to have an abnormal four-chamber view at the time of the routine scan. One 
may speculate if the four-chamber view had actually been properly obtained, and if so, 
whether it then had been correctly interpreted. Both the technique to obtain a correct 
four-chamber view and the way it is interpreted are a consequence of basic learning and 
experience. Ultrasound experience did seem to be of importance when it came to 
interpreting the view, as the experienced sonographer/midwives recognized 
significantly more of the expected abnormal four-chamber views than did the less 
experienced sonographer/midwives. But, the experienced sonographer/midwives also 
missed CHDs with abnormal four-chamber views, emphasizing the need for extra focus 
on this basic view (Chaoui 2003b). 
 
The success in obtaining the sonographic views of the great arteries seemed to be more 
dependent on experience than on the ability to obtain the four-chamber view. The 
differences between the experienced and the less experienced sonographer/midwives 
were significant, and the main pulmonary artery seemed like the most difficult vessel to 
obtain. Since this registration was carried out, the three-vessel view has been introduced 
as an easy view to obtain the great arteries (Yoo et al. 1997), which may affect the way 
the great arteries are imaged today. Still, the significant difference between the 
sonographer/midwives clearly demonstrated the importance of experience. Even the 
experienced sonographer/midwives showed improvement of their results, most likely 
due to the extra focus on the four-chamber view and the great arteries (Figure 20). Thus, 
intensive focus and training on the examination of the fetal heart seem to be needed for 
all categories of ultrasound personnel. The poor detection rates of CHDs reported from 
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non-selected populations (Crane et al. 1994, Buskens et al. 1996, Bull 1999, Garne et 
al. 2001) may indicate that the basic training has not paid enough attention to the 
teaching of the four-chamber view and the great arteries of the fetal heart, and that there 
is potential for improvement. 
 
Statistically, the differences found between the experienced and the less experienced 
sonographer/midwives were not all significant, but the consistent trend between them 
does suggest a difference. A comparison of the experienced sonographer/midwives’ 
ability to detect major CHDs to the less experienced sonographer/midwives’ results 
showed that the experienced personnel did better. When breaking the CHDs down to 
isolated CHDs, ductal dependent CHDs and CHDs with associated malformations 
including abnormal karyotype, we found the same tendency, i.e. that the experienced 
sonographer/midwives did better than the less experienced sonographer/midwives. 
Because heart defects are low in number, a background population of three times the 
size of our population, approximately 100,000 fetuses, would be needed to reach a level 
of significance given the same detection rates. However, the experienced 
sonographer/midwives did significantly better in obtaining both the four-chamber view 
and the great arteries – details necessary for the detection of CHDs. In addition, the 
experienced sonographer/midwives’ ability to recognize an abnormal four-chamber 
view was significantly better than that of the less experienced sonographer/midwives. 
The significant improvement in the ability to obtain fetal heart structures over time also 
emphasizes the difference between the experienced and less experienced 
sonographer/midwives. 
 
The gestational age may be of importance for the detection of CHDs. Several studies 
have shown that the fetal heart structures are more difficult to image prior to 18 weeks 
than after 18 weeks (Schwärzler et al. 1999b). As much as 40% of the fetuses with a 
major CHD missed prenatally in the present study had a routine scan performed prior to 
18 completed weeks. According to published data, some of these might have been 
detected if the ultrasound examination had been carried out at a later gestation (Allan 
2003). The results from Paper I demonstrating a higher success in obtaining the four-
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chamber view after 18 weeks, still seem to be valid. Despite the advances in technology, 
it is interesting to notice that those offering both an early and second trimester 
ultrasound examination prefer to do the second trimester anomaly scan between 20-24 
weeks (Gembruch et al. 1993, Zosmer et al. 1999, Rustico et al. 2000). It is worth 
noting, though, that the gestational age most likely is only one of several factors 
involved in the poor detection of CHDs. There were no differences between the 
experienced and the less experienced sonographer/midwives when it came to detecting 
CHDs prior to 18 weeks of gestation, but the difference was significantly better for the 
experienced sonographer/midwives after 18 completed weeks. It may be that the less 
experienced sonographer/midwives had problems detecting the CHDs no matter what 
the gestation, and that experience still is important even at later gestations.  
 
To further improve the results, it has been suggested that additional views of the fetal 
heart and new modalities be incorporated to the fetal heart examination (Yoo et al. 
1997, Chaoui and McEwing 2003). Adding the great arteries to the four-chamber view 
clearly increased the detection rate in the present study. The present study also showed 
that the ability to obtain the four-chamber view at the routine scan increased to 99%, but 
still too many CHDs with an abnormal four-chamber view were missed. Clearly, the 
four-chamber view was evaluated as normal when it was not. Also, too many CHDs 
with a normal four-chamber view were missed, underscoring that the examination of the 
great arteries was not sufficiently mastered. It may be that the potential of including the 
great arteries can not be fully exhausted as long as the four-chamber view is not 
properly mastered. The stepwise introduction to the fetal heart examination, suggested 
by Allan in 1986, still seems to be fundamental to the success in fetal heart scanning. 
The first step, the four-chamber view, should be mastered before the next step is 
considered (Allan 1986, Sharland 2004). Adding even more views to the fetal heart 
examination may not give the expected results as long as the basic views have not been 
properly learned. 
 
The present study emphasizes the importance of dedicated personnel performing the 
obstetric ultrasound examinations, as experience seems crucial for the detection of 
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defects, specifically of the fetal heart. In most non-selected populations, sonographers 
with basic ultrasound training are performing the routine examinations. After years 
working with ultrasound, sonographers develop an awareness to pathology gained from 
intensive experience (Cullen et al. 1992). This was also shown in the present study as 
three true CHDs were suspected by the sonographer/midwives, but later evaluated as 
normal by the consultant physician. It takes years to develop this experience; thus, fetal 
ultrasound examinations should be performed by personnel specifically trained in 
obstetric ultrasound (Cullen et al. 1992). Non-dedicated personnel will probably not get 
enough experience and will, over time, remain less experienced ultrasound personnel. 
 
The long learning curve to become experienced in fetal heart scanning may be 
shortened by a more focused education on the four-chamber view and the great arteries. 
The educational and training systems today expect the sonographers to build up their 
experience through a high number of ultrasound examinations following their training. 
The busy schedule most sonographers are faced with does not give much room for 
developing scanning skills; this is demonstrated by the long learning curve. Since 
studies have shown that the fetal heart is more difficult to examine than other fetal 
organs (Stoll et al. 2002a, Levi et al. 2003), the educational sites have to accept that the 
heart needs more focus during the time of education. With a better basic learning 
process, the learning curve may increase faster. 
 
What have we learned during the 20 years since the sonographic appearance of the fetal 
heart and the subsequent demand for increasing the detection rates of CHDs? During all 
these years the ultrasound equipment has improved significantly, making it easier to 
obtain the details of the fetal heart, but also requiring more technological knowledge 
from the ultrasound operator. Already in the late eighties (Paper II, Phase II) we 
demonstrated the importance of utilizing the correct equipment when examining the 
fetal heart: using a 5 MHz transducer gave a significantly better image of the four-
chamber view than the 3.5 MHz transducer. Although most modern ultrasound 
machines are equipped with multifrequency transducers, a proper image of the fetal 
heart still requires the ultrasound operator’s knowledge and awareness of correct use 
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and adjustments of the ultrasound machine; these need to be optimized for the imaging 
of the fetal heart. 
 
In continuation of the discussion on equipment, the poor detection rates of CHDs may 
also be a result of old and poor ultrasound equipment. The fact that most of the fetuses 
with CHD are found in non-selected populations (Allan et al. 1994, Maher et al. 1994, 
Carvalho et al. 2002, Åmark et al. 2004) means that the detection of fetuses with CHD 
needs to be done in the routine setting. This scan is often the only opportunity to detect 
CHDs prenatally, as ultrasound examinations later in the pregnancy often are done on 
indications only. If the ultrasound machines used during the routine scan are of poor 
quality, this may affect the detection rate of defects. This is an organizational issue that 
should be addressed by each ultrasound department. 
 
Experience is of importance for the detection of CHD (Cullen et al. 1992, Hunter et al. 
2000, Carvalho et al. 2002, Wong et al. 2003). When the four-chamber view was 
introduced and evaluated (Paper II, Phase II), a significant improvement in the ability to 
obtain this view was observed over time. The same results were found in the present 
study with the introduction of the great arteries. For both periods, the learning curve 
was relatively long, despite better ultrasound equipment during the present study. Thus, 
good equipment is not the only answer to better imaging of the heart; experience must 
also be considered. The experienced sonographer/midwives were superior to the less 
experienced sonographer/midwives in obtaining details and detecting defects of the fetal 
heart. Thus, if only experienced sonographer/midwives performed the routine 
examinations, one would expect a further increase in the prenatal detection rate of major 
CHDs. The opposite situation is often the reality in ultrasound departments. 
Experienced sonographer/midwives tend to end up with administrative work while less 
experienced sonographer/midwives are left on their own to do the majority of the scans 
to gain experience. Since there always will be a need for recruitment of new personnel, 
the basic education must focus on the need for more experience in fetal heart scanning. 
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To provide the best possible fetal heart scans, we must apply quality assurance to the 
work we do. This has already been addressed by the Fetal Medicine Foundation in 
London. The Fetal Medicine Foundation requires minimum standard for the ultrasound 
examination, and has shown the potential of nuchal translucency measurement in 
detecting developmental disorders when this measurement is performed with a high 
degree of accuracy and quality assessment (Nicolaides et al. 1999). The importance of 
complying with a detailed procedure when measuring the nuchal translucency has been 
encouraged in numerous courses around the world to ensure that this accurate and 
standardized method is followed. Multiple series have shown that focusing on nuchal 
translucency measurements as taught by the Fetal Medicine Foundation has good results 
(Hafner et al. 1998, Hyett et al. 1997, Schwärzler et al. 1999). This way of 
standardization and assessment of nuchal translucency measurements probably also 
applies to other aspects of the fetal examination. Based on results from the present study 
there is reason to believe that a standardized procedure for the fetal heart examination 
should be given increased focus. Images of the nuchal translucency that do not follow 
the standardized method are not accepted by the Fetal Medicine Foundation quality 
assessment system. There is no such quality check when it comes to images from the 
fetal heart. If the examination of the four-chamber view with all its details described 20 
years ago (Allan 1986) had been followed up by the same rules and quality assessment 
as for the nuchal translucency measurement, this would most likely have made a great 
impact on the examination of the fetal heart and thus the detection of CHDs. 
 
Experience shows that it takes time to learn the ultrasound technique in general. As a 
consequence, most post-graduate ultrasound educational programs last for a minimum 
of one year. During that year, the basic ultrasound technique has to be learned and the 
ultrasound images must be understood and correctly interpreted. Obtaining correct 
images is dependent on the operator’s understanding and mastering of the ultrasound 
technique. The poor detection rates reported on CHDs may suggest that the basic 
technique has not been properly understood and learned. The educational sites’ future 
focus should be on each ultrasound operator’s skills to obtain and interpret sections 
through the fetal heart; time must be allowed for necessary maturation of these 
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ultrasound skills. The technique to obtain the correct four-chamber view and the 
interpretation of all the details from this view have to be mastered before the great 
arteries are added. As the basic ultrasound education includes a range of different 
subjects to be learned, the great arteries may be introduced through additional 
ultrasound courses following the first year of training, perhaps as an obligatory 
extension of the basic education. 
 
Paper V 
Introduction of three-dimensional ultrasound imaging of the fetal heart (TDOG) 
A new 3D technique utilizing tissue Doppler as a gating signal was introduced. The 
purpose of this technique was to see if structures in the fetal heart could be more easily 
obtained and imaged than was possible with the conventional 2D ultrasound technique. 
The images were of adequate quality for four of the eight fetuses examined. Two fetuses 
showed several motion artifacts and for two fetuses there was no adequate access to the 
four-chamber view during the scanning time. To cover the fetal heart with maximal 
diameter of 2 cm at a depth of 5–7 cm, a scanning angle of approximately 25˚ showed 
good agreement between the B-mode and a planar slice. 
 
The best image quality of the 3D reconstruction was achieved by a compromise 
between high B-mode quality and high frame rate. Second harmonic imaging gave the 
highest lateral resolution and was used on all recordings. As for the gating signal, 
cardiac motion could positively be used, even when the motion was not visible within 
the B-mode image. The basic signal used for the tissue Doppler synchronization 
emphasized strong echoes and massive motion of tissue in the ultrasound beam 
direction. 
 
The variation in the quality of the reconstructions between different recordings were 
mainly due to fetal position not suitable for high-quality B-mode imaging of the fetal 
heart, fetal movements during the sweep and uneven probe motion during the sweep. 
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Figure 21 demonstrates reconstructed volume projections of the heart from a 24-week 
fetus. All images were retrospectively produced from one cineloop of 3D data, derived 
by apical insonation. 
 
Figure 21  Volume projection of the heart of a 24 weeks fetus. a) Apical four-chamber view. b) Subcostal 
four-chamber view. c) Ascending aorta. d) Three-vessel view. c) Short-axis view of the great arteries. 
f) Aortic arch. g) Ductal arch. h) Long-axis view of inferior and superior venae cavae. 
 
 
Comments: 
Dynamic 3D imaging of the fetus has received increasing interest during the past few 
years (Hata et al. 1998, Pöhls and Rempen 1998). This may be a natural result of the 
rapid development of technology and imaging modalities to meet the demand of 
increased image quality and thus the information derived from those images. The 
interest for dynamic 3D imaging of the fetal heart may also be a result of poor detection 
rates of major CHDs and the recognition of the fetal heart as a difficult organ to 
examine with 2D ultrasound imaging (Chaoui 2003b, Sharland 2004). 
 
The acquisition techniques with 3D ultrasound imaging have been difficult, and 
different approaches have been investigated, such as using both gated and non-gated B-
mode reconstruction techniques (Merz et al. 1995, Sklansky et al. 1998) or real-time 3D 
acquisition using a 2D array transducer (Deng et al. 2002a). Different gating techniques 
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have also been studied, including operator input based on an M-mode display (Deng et 
al. 1996), temporal Fourier transforms of the volume data itself (Sklansky et al. 1998) 
and Doppler spectrum acquisition and analysis performed by an independent ultrasound 
system (Deng et al. 2000, Deng et al. 2002b). The spatio-temporal image correlation 
(STIC) technique has been used to produce 3D gray scale images with the gating signal 
automatically detected from the underlying B-mode sequence (Devore et al. 2003, 
Viñals et al. 2003), and to reconstruct 3D color Doppler images (Chaoui et al. 2004, 
Gonçalves et al. 2004). 3D images of the fetal heart have also been obtained by free-
hand scanning gated with cardiotocography (CTG) (Herberg et al. 2003). 
 
The current study looked into another approach, using 2D tissue Doppler from the fetal 
heart to generate the gating signal (TDOG). Tissue Doppler has been used for clinical 
application since 1989, first described by Isaaz et al. (1989) to measure the low velocity 
motion of the left ventricular posterior wall. The higher velocity in blood than in other 
tissue during normal circumstances results in a lower Doppler shift from the myocardial 
wall than in blood. The tissue signal will have a stronger amplitude because of more 
scatter returning from tissue than from blood. Thus, the tissue Doppler signal can be 
recorded either by low pass filtering or gain damping, or with a combination of both 
(Brodin 2004). For the TDOG method, those strong tissue Doppler signals could 
positively contribute to the gating signal. 
 
Spatial and temporal tracking, or gating, is usually preferred when 3D images are to be 
acquired in-utero, during which fetal movements, maternal respiration or probe-induced 
movements often occur (Deng 2003). Nongated cardiac imaging generates a single 
volume that mixes together several parts of the cardiac cycle, resulting in suboptimal 
accuracy and resolution; the gated techniques have shown to improve the resolution of 
image planes generated from volumetric data (Sklansky et al. 1998). Electrocardiogram 
used for gating in 3D echocardiography in infants, children and adults has been difficult 
to achieve in fetuses, although gating by cardiotocography in the fetus has been 
attempted (Herberg et al. 2003). 
 
  
 82 
The disadvantages of using two different systems are the inconvenience of two devices, 
in addition to possible artifacts caused by acoustic interference between the transducers 
(Deng et al. 2000, Downey et al. 2005). Such acquisition artifacts were noted during the 
present study when Doppler CW data were recorded simultaneously with the tissue 
Doppler for quality assessment. To ease the use for clinical setting, the gating signals 
should be easy to obtain, accurate and technically reliable. With the TDOG-method, 
tissue Doppler data can be acquired simultaneously and with the same transducer as the 
B-mode data, allowing the recording of tissue Doppler data as part of a gated 3D scan.  
 
Handheld sweeps allow the sonographer to make fine adjustments during the sweep to 
minimize acoustic shadowing, but the image quality depends largely on how smoothly 
and steadily the transducer is moved (Downey et al. 2000, Sklansky 2004). A long 
sweep yields a high scan plane density as a high number of consecutive cineloops 
become neighboring planes in the 3D dataset. However, too long a sweep makes it 
difficult to perform the sweep with constant tilt velocity. A method in which the 
transducer is kept stationary and electronic scanning with a 2D array processes the 
echoes to generate 3D information may be an alternative to freehand systems (Downey 
et al. 2000), used for the STIC technique (DeVore et al. 2003, Viñals et al. 2003). 
However, the STIC-technique is a post-processing technique and does not allow 3D in 
real-time scanning, i.e. 4D scanning. 
 
Acquiring volumetric data within a few seconds from a single window, with the 
possibility of a retrospective visualization of the heart in a multiplanar display is of 
interest. Such a procedure reduces the scanning time, is independent of the experience 
of the ultrasound operator, allows reconstruction of standardized fetal 
echocardiographic views without the pregnant woman present, and allows 2D 
reconstruction of views from the fetal heart not accessible by regular 2D B-mode 
imaging (Budorick and Millman 2000, Sklansky 2004). On the other hand, there are 
also limitations to 3D ultrasound. The present study showed that important factors for 
an optimal and useful recording were: no bone shadows or other disturbances in front of 
the fetal heart, the heart positioned within a certain distance from the ultrasound 
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transducer (ideally less than 6 cm), and no fetal or respiratory motion during the sweep 
time. These limitations well known from 2D ultrasound (DeVore et al. 1993, Hendler et 
al. 2005), also recognized from 3D imaging (Budorick and Millman 2000, Hull et al. 
2000, Abuhamad 2005), should be expected, as long as the 3D reconstructions are based 
on 2D recordings. 
 
Performance of the 3D scan by less experienced ultrasound personnel may be 
questioned. Difficult fetal position, which can affect the acquisition of the data, can be 
dealt with by using an alternative insonation angle gained through experience. Data 
from Paper IV show that it takes time and experience to obtain adequate images of the 
fetal heart needed for 3D reconstruction. In addition, the acquisition, display and 
manipulation of 3D volumes require experience (Abuhamad 2005). Thus, as the 
utilization of the multiplanar review may be time-consuming, the timesaving factor may 
not be obvious (Budorick and Millman 2000). Standardization in the acquisition and 
display of 3D volumes may ease the training process (Abuhamad 2005). 
 
There are advantages and disadvantages with both 2D imaging systems and 3D imaging 
systems. Some will remain the same for both imaging modalities as long as 2D images 
are acquired to reconstruct 3D images. The present paper demonstrated the weakness of 
the ultrasound system due to poor resolution when the perimembranous part of the 
ventricle septum was to be imaged from an apical view of the heart. The nature of 
ultrasound physics cannot be overruled, thus one single 3D ultrasound insonation angle 
will not give an optimal image quality of all structures, regardless of resolution. A 
typical example would be the imaging of the ventricular septum. In the apical view 
using 3D ultrasound, it still would appear very thin (Figure 21), whereas in the long-
axis view, true imaging of the texture and thickness would be appropriate. 
 
Today most 3D ultrasound images represent a compromise between the optimal 
diagnostic perspective (large data set, higher-resolution 3D images) and what the 
computers actually are capable of processing (Downey et al. 2000). With the increased 
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clinical use of 3D ultrasound and further advances in computer technology, 3D 
ultrasound may play an important role in obstetric ultrasound. 
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SUMMARY 
Background 
The second trimester fetal ultrasound examination has become an integrated and 
important part of prenatal care. One of the aims of this scan is to detect developmental 
disorders which might have consequences for the management of the pregnancy and the 
neonatal period. The fetal heart has received particular attention, as heart defects seem 
difficult to detect prenatally and data show when CHDs are prenatally detected, that the 
outcome improved. As a teaching institution, our focus has been on improvement in the 
fetal heart examination. The knowledge about what kind of CHDs we do and do not 
detect is of importance in order to understand why we fail to detect CHDs and to learn 
about the next steps needed to improve the results.  
 
Purpose 
The objectives of the studies were to implement and prospectively evaluate new 
examination procedures of the fetal heart at the second trimester routine examination, in 
order to increase the prenatal detection rate of CHDs (Papers I, II, III and V). The 
training and experience of the ultrasound personnel were evaluated to see if educational 
aspects were factors that would have influence on the prenatal detection of CHDs and to 
evaluate current ultrasound-training programs (Paper IV). Finally, the CHD cases were 
followed into the postnatal period to get a better understanding of the outcome, in order 
to improve the basis and the accuracy for our counseling once the defects are detected 
(Papers II and III). 
 
Material and methods 
A well-defined non-selected population of 42,381 fetuses was prospectively studied 
from August 1986–December 2001. Of those, 41,354 (98%) received an ultrasound 
examination at our hospital and formed the study population (Papers I, II, III and V). 
The second trimester routine ultrasound examinations were scheduled at 18 completed 
weeks and were mainly performed by specially trained sonographer/midwives. In Paper 
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IV, these sonographer/midwives were grouped as experienced or less experienced and 
constituted the study population. 
 
During the regular second trimester routine scan, the four-chamber view was 
incorporated into the fetal heart examination (Papers I and II), and later the views of the 
great arteries were added (Paper III). Starting in 1995, a new scan was offered at 
approximately 20 weeks of gestation if a proper four-chamber view had not been seen at 
the routine examination (Papers III and IV). In 8 of these fetuses, a new method to 
image the fetal heart, Tissue Doppler gated (TDOG) 3D ultrasound, was evaluated 
(Paper V). 
 
A heart defect was retrospectively classified as major or minor after a final diagnosis 
was achieved. The major CHDs were grouped as isolated; abnormal karyotype; 
associated malformations (Papers III and IV). Fetal karyotyping was offered in all 
prenatally detected cases. Every fetus/child was followed-up to ensure outcome data. 
The longest period of follow-up for the live-born children was 13 years (Paper III). 
 
Results 
A four-chamber view of the fetal heart could be obtained in 96% of the fetuses at 18–21 
weeks of gestation, the time of the second trimester routine scan. Prior to 18 weeks, the 
results were poorer. The results with a 5 MHz transducer were significantly better than 
with a 3.5 MHz transducer. A significant improvement in the ability to obtain the four-
chamber view was noticed over time for the sonographer/midwives performing the 
ultrasound examinations (Paper I). 
 
Introducing the four-chamber view into the routine examination increased the detection 
rate of major CHDs at that scan from 18 to 26% (Paper II). By adding the views of the 
great arteries, the detection rate further increased to 39% (Paper III). During this last 
period (Paper III), 9% of the major CHDs in the study population were detected prior to 
the routine scan. 
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An abnormal karyotype was found in 38% of the 97 major CHDs, and 18% had 
associated malformations with normal karyotype (Paper III). Major CHDs with 
associated malformations including abnormal karyotype were significantly more often 
detected than were isolated major CHDs. Of the isolated ductal dependent major CHDs, 
48% were detected prenatally. Of the isolated major CHDs missed prenatally, 58% 
would be expected to have an abnormal four-chamber view. 
 
The incidence of major CHDs was constant between 3.0–3.7/1000 through the complete 
study period. The incidence of minor CHDs increased from 7.4–11.3/1000 through the 
same period (Papers II and III).  
 
There were significant differences in the outcomes between the fetuses with a CHD 
detected prenatally compared to postnatally (Paper III). Of the prenatally detected cases, 
44% of the pregnancies were terminated. Of those, 58% had associated lethal 
chromosome aberrations, and the rest, except for the trisomy 21 cases, were severe 
anomalies. Intrauterine fetal death occurred in 15% of the fetuses with a detected CHD, 
but in none of those not detected prenatally. Of the prenatally detected cases, 42% were 
born alive. At the age of 2 years, only 27% of the children with prenatally detected 
CHDs were alive. The corresponding numbers for those detected postnatally were 98% 
and 81%, respectively. 
 
Compared to the less experienced sonographer/midwives, the experienced 
sonographer/midwives showed significantly better results in obtaining a view of the 
great arteries and in recognizing an abnormal four-chamber view (Paper IV). The 
experienced sonographer/midwives did better in the overall detection of major CHDs, 
as well as in the detection of isolated CHDs and CHDs with associated malformations. 
The less experienced sonographer/midwives showed a significant improvement over 
time in their ability to obtain the heart structures and reach the level of the experienced 
sonographer/midwives. CHDs with an abnormal four-chamber view were missed in 
both groups. 
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With the new 3D technique utilizing tissue Doppler as a gating signal, it was possible to 
obtain images of adequate quality in four out of eight fetuses and reconstructed volume 
projections of the heart from one cineloop of 3D data could be demonstrated (Paper V). 
Two fetuses showed several motion artifacts; in two fetuses, a four-chamber view could 
not be obtained due to awkward fetal position.  
 
Conclusions 
The fetal heart examination, and thus the prenatal detection of CHDs, is still a challenge 
in non-selected populations. Incorporation of the four-chamber view and the great 
arteries increases the detection rate to some extent, but not as much as expected. The 
fetuses with the most severe CHDs and associated malformations seem easier to detect 
than fetuses with isolated CHDs. 
 
Education and training seem crucial for the ability to obtain fetal heart structures. 
Obtaining and interpreting basic views of the fetal heart failed for all 
sonographer/midwives, emphasizing that the basic education on the fetal heart 
examination needs to be strengthened. Both the views of the four chambers and the 
great arteries must be mastered before new views and advanced technology are added. 
 
Future aspects 
Recent data show that results for newborns with a heart defect detected prenatally are 
improving. To detect the major CHDs, the sonographer/midwife must master the 2D 
ultrasound technique as well as the evaluation of the four-chamber view and the great 
arteries. Thus, the fetal heart examination must be given special attention in the 
education and training of sonographer/midwives. With a thorough basic understanding 
and experience, advanced ultrasound techniques may be more easily adopted. 
 
Recent studies also indicate that the 11–13+6 week scan might be of importance for the 
overall detection of heart defects during pregnancy. 
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CORRECTIONS 
Paper II Page 376, second column, line six: 
“Eighteen percent of the critical and 11%...” should be “Fifteen percent 
of the critical and 11%...”. 
 
Page 377, Table 10, first line under “Outcome”: 
“Intrauterine fetal death” should be “Alive, died 2 days old, Trisomy 18”. 
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